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Cell adhesion to proteins adsorbed onto implanted surfaces is particularly 
important to host responses in biomedical and tissue engineering applications.  
Biomaterial surface properties influence the type, quantity and functional presentation 
(activity) of proteins adsorbed upon contact with physiological fluids, and modulate 
subsequent cell response.  Cell adhesion to extracellular matrix proteins (e.g. fibronectin) 
is primarily mediated by the integrin family of cell-surface receptors.  Integrins not only 
anchor cells, supporting cell spreading and migration, but also trigger signals that 
regulate survival, proliferation and differentiation.  A fundamental understanding of the 
adhesive interactions at the biomaterial interface is critical to the rational design of 
biomaterial surfaces.  Using model surfaces of self-assembled monolayers of alkanethiols 
on gold presenting well-defined surface chemistries (CH3, OH, COOH, NH2), we 
investigated the effects of surface chemistry on osteoblastic differentiation.  We report 
that surface chemistry effectively modulates fibronectin adsorption, integrin binding, 
focal adhesion assembly and signaling to direct the osteoblast cellular functions of 
adhesion strength, gene expression and matrix mineralization.  Specifically, surfaces 
presenting OH and NH2 functionalities provide enhanced functional presentation of 
adsorbed fibronectin, promoting specificity of integrin binding as well as elevating focal 
adhesion assembly and signaling.  Furthermore, the OH and NH2 surfaces supported 
elevated levels of osteoblast differentiation as evidenced by osteoblast-specific gene 
expression and matrix mineralization.  These results contribute to the development of 
design principles for the engineering of surfaces that direct cell adhesion for biomedical 
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and tissue engineering applications.  In particular, the understanding provided by this 






       CHAPTER 1: SPECIFIC AIMS 
SPECIFIC AIMS 
 
The focus of this project was the engineering of surfaces that modulate cell 
adhesion in order to direct cell function.  Cell adhesion to extracellular matrix (ECM) 
proteins is critical to physiological and pathological processes such as tissue development 
and homeostasis, blood clotting, wound healing and cancer metastasis.  In addition, cell 
adhesion to proteins adsorbed onto synthetic surfaces directs cell function in numerous 
biomedical applications.  Cell adhesion is a highly regulated process involving receptor-
ligand binding, cell spreading and formation of focal adhesions and actin stress fibers.  Cell 
adhesion to ECM proteins is primarily mediated by the integrin family of transmembrane 
adhesion receptors.  Integrins provide a connection between the cytoskeleton and the ECM, 
anchoring cells to provide tissue structure and integrity.  Integrins also function as signal 
transducers, relaying information contained in the surrounding ECM to intracellular 
signaling pathways that control cell survival, proliferation and differentiation.  Upon ligand 
binding, integrins cluster to form focal adhesions.  Focal adhesions are the closest points of 
contact between the cell membrane and ECM, and are the sites of greatest cell adhesion.  
Focal adhesions are complexes that consist of not only adhesion receptors and cytoskeletal 
proteins (e.g., vinculin, talin, actin fibers), but also include abundant signaling molecules 
(e.g., focal adhesion kinase (FAK) and src-family kinases).  
The ECM protein fibronectin (FN) plays a central role in the proliferation and 
differentiation of numerous cell types.  For example, in osteoblasts, integrin-mediated 
adhesion to FN regulates cell survival, proliferation and expression of osteoblast-specific 
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genes and matrix mineralization, and integrin- and fibronectin-blocking antibodies inhibit 
osteoblastic gene expression and matrix mineralization.  The critical importance of 
integrin-FN interactions in cell function has significant implications in the development 
of surfaces for biomaterial and tissue engineering applications.  The overall objective of 
this project was to identify surface chemistries that modulate adsorbed FN 
conformation to direct integrin-FN binding in order to direct cell function.  Our 
central hypothesis was that surface chemistry directs cell function by altering 
integrin-FN binding due to surface-dependent modulation of FN conformation.  This 
hypothesis is supported by previous studies in our laboratory demonstrating that 
substrate-dependent differences in FN conformation modulate integrin binding and 
control switching between myoblast proliferation and differentiation.  A significant 
advantage of our experimental system over previous studies is the use of model surfaces 
consisting of self-assembled monolayers (SAMs) of alkanethiols on gold presenting well-
defined chemistries.  This system, coupled with robust bioengineering and cell biology 
approaches, allows a systematic analysis of the effects of surface chemistry on cell 
function. 
 
AIM 1: TO ANALYZE DIFFERENCES IN ADSORBED FN CONFORMATION 
AS A FUNCTION OF SURFACE CHEMISTRY (CH3, OH, COOH, NH2) USING 
MONOCLONAL ANTIBODIES.  The structure of FN adsorbed onto SAMs was 
investigated using a panel of monoclonal antibodies directed against different FN 
domains.  Differences in antibody binding affinity reflect differences in adsorbed FN 
conformation among SAMs. 
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Hypothesis: Surface chemistry significantly alters the structure of adsorbed FN, including 
regions within the central integrin-binding domain. 
 
AIM 2: TO QUANTIFY INTEGRIN RECEPTOR BINDING TO FN ADSORBED 
ONTO SAMS AND ANALYZE SUBSTRATE-DEPENDENT DIFFERENCES IN 
FOCAL ADHESION FORMATION AND SIGNALING.  Integrin binding to 
adsorbed FN was quantified via a cross-linking/extraction biochemical method.  
Cytoskeletal and signaling proteins (vinculin, talin, paxillin and α-actinin, FAK) 
localized to focal adhesions were quantified as a function of FN density by a wet-
cleaving/ELISA technique as well as immunofluorescence staining.  FAK 
phosphorylation, a measure of integrin-mediated signaling, was analyzed by Western 
blotting. 
Hypothesis: Substrate-dependent changes in FN conformation modulate integrin receptor 
binding, focal adhesion formation (composition and distribution) and signaling. 
 
AIM 3: TO ANALYZE OSTEOBLAST-SPECIFIC GENE EXPRESSION AND 
MATRIX MINERALIZATION OF MC3T3-E1 CELLS CULTURED ON FN-
COATED SAMS.  Osteoblast-specific gene expression of a cell model representing 
immature osteoblasts, MC3T3-E1 cells, was analyzed through real-time RT-PCR.  
Alkaline phosphatase activity and matrix mineralization was quantified using a 
biochemical assay and von Kossa staining, respectively. 
Hypothesis: Substrate-dependent changes in integrin binding and focal adhesion 




Control of cell receptor-ligand interactions through the underlying substrata 
represents a versatile approach for the rational design of materials to manipulate cellular 
responses for biotechnological and biomedical applications.  Currently, a major obstacle in 
biomaterial and tissue engineering applications is the in vitro loss of differentiated 
phenotypes.  By implementing a bioengineering analysis of integrin-mediated adhesion as a 
function of the underlying chemistry, we established a fundamental framework for the 
engineering of surfaces to direct cell function.  By focusing on osteoblasts, the cells 
responsible for bone matrix production and mineralization, this research is directly relevant 
to the engineering of surfaces that promote osteoblast function, which may lead to 
improvements in bioactive implant coatings, and 3-D scaffolds for bone tissue engineering. 
 
THESIS OUTLINE 
This thesis addresses the Specific Aims outlined above, and is organized in the 
following manner.  Chapter 2 provides background of the field and the significance of this 
project.  Chapter 3 details the validation of new techniques developed to quantify integrin 
binding and focal adhesion assembly.  These techniques were then used as described in 
Chapter 4 and Chapter 5 to address topics in Specific Aim 2.  Chapter 4 presents results 
demonstrating that surface chemistry modulates fibronectin conformation and directs 
integrin binding (Specific Aim 1 and part of Specific Aim 2).  Chapter 5 provides data 
showing that surface chemistry modulates focal adhesion composition and signaling 
through changes in integrin binding, addressing the remainder of Specific Aim 2.  Chapter 
6 details data demonstrating that surface chemistry directs osteoblastic differentiation 
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(Specific Aim 3).  Finally, Chapter 7 gives overall conclusions and recommendations for 
future work.    
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                          CHAPTER 2: BACKGROUND AND SIGNIFICANCE 
BACKGROUND AND SIGNIFICANCE 
 
BONE TISSUE DEFICIENCIES 
Complications associated with bone tissue reconstruction procedures including 
poor prosthesis-bone integration, non-union fractures, and bone loss associated with 
trauma, joint replacements and tumors, have an enormous socioeconomic impact in the 
U.S., in terms of both personal disability and resultant health care costs.  For example, 
over 700,000 joint arthroplasties were performed in 2000, incurring a cost of 
approximately $15 billion.1  Although joint replacements are relatively successful, often 
able to function for over 10 years, the long-term success of these arthroplasties is limited 
by implant loosening and wear, causing patient discomfort and pain and requiring 
revision surgery.2  Similarly, bone grafting to treat non-unions and bone loss is critical to 
numerous orthopedic and craniofacial applications.3  For example, approximately 
600,000 spinal fusion and general orthopedic grafting procedures are performed yearly in 
the U.S.4  In addition, about 10% of the 6 million bone fractures treated annually require 
auxiliary grafting.5  Treatments using auto- and allo-grafts have had the most success, 
however, these treatments are limited by donor bone supply and morbidity, reduced 
bioactivity and risk of disease transmission. 
 
IMPLANT SURFACE TECHNOLOGIES 
Considerable efforts have focused on implant surface technologies, particularly 
porous coatings for bone ingrowth and bone-bonding ceramic coatings, to promote 
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integration with surrounding bone.6  Osseous implants often fail by a combination of 
factors, including inflammatory responses to wear debris, infection, implant motion, and 
inadequate mechanical loading.7  These factors result in a reduction of local bone 
production, an increase in bone resorption, or both.7  One critical parameter in the long-
term success of osseous implants is initial mechanical fixation.  Most orthopedic implants 
with poor initial fixation eventually fail clinically, a problem that is exacerbated by wear 
debris. 8-10  Consequently, considerable effort has focused on the development of implant 
surface technologies, particularly micro- and macro-textured implants for bone ingrowth 
and bone-bonding ceramics, to promote osseointegration, defined as direct bone 
apposition and load transfer.11,12  
 Implants with porous metal coatings have been used to provide cavities of several 
hundred micrometers available for bone ingrowth and fixation.13  While these designs 
generally perform well clinically, bone ingrowth and implant fixation are highly variable, 
especially in revision surgeries.14-17  Micro-textured surfaces, such as grit-blasted 
titanium, have exhibited excellent osseointegration and performance in dental 
applications.18,19  However, they have had limited success in orthopedic settings due to 
inadequate initial fixation.20,21  An alternative strategy to promote osseointegration 
focuses on bioactive coatings.22  Bioactive materials, namely calcium phosphate and 
bioactive ceramics such as hydroxyapatite, react with physiological fluids to enhance 
bone formation and bond directly to bone.23  Bioactive ceramics have been generally 
successful in non-load bearing applications, but poor fracture properties and loss of 
bioactivity resulting from manufacturing-related alterations in composition/structure have 
limited their application as implant coatings and structural replacements.24  Therefore 
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there is still a significant need for surface technologies that enhance implant 
osseointegration. 
BONE GRAFT SUBSTRATES 
Bone grafting is critical to numerous orthopedic and craniofacial applications.3  
Autogenous bone, harvested from the patient’s iliac crest, is presently the preferred 
material. 3  Autografts, however, are limited by donor bone supply, donor site morbidity 
and pain, anatomical and structural complications and graft resorption.25  Because of 
these complications, allogenic bone has been used as grafting material.26  Although tissue 
processing minimizes immune complications, allografts suffer from poor mechanical 
properties, graft resorption, reduced osteogenic capacity, and risk of disease transmission. 
25  Consequently, extensive research has focused on the development of synthetic 
materials as alternatives to biological grafts.  However, synthetic materials generally 
incite foreign body/inflammatory responses and exhibit poor osteogenic cell interactions 
and bone formation.27  Notable exceptions are bioactive ceramics and glasses, which 
exhibit osteoconductive properties.23,24  These materials, however, are limited by poor 
mechanical properties and inadequate dissolution/precipitation rates as well as difficulties 
in manufacturing and processing.28,29 
 Delivery of osteoinductive factors, such as BMPs, has been successfully applied 
to augment local bone repair and several formulations are available for clinical 
applications.30-32  However, the clinical efficacy of these treatments continues to be 
hampered by inadequate delivery carriers, release kinetics, dosage, and potency.31,33  
Genetic engineering strategies to deliver osteoinductive genes to osseous defects have 
emerged as efficient approaches to enhance bone formation.34,35  Recent studies have 
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demonstrated significant healing rates in fractures and segmental defects treated with 
vectors encoding for BMP or BMP-expressing cells.36-41  Although these initiatives are 
promising, further studies are required to establish the efficacy, immunogenicity, and 
long-term safety of these genetic engineering approaches. 
  
TISSUE ENGINEERING STRATEGIES 
Due to the limitations associated with current grafting methods, recent research 
efforts have concentrated on tissue engineering strategies, incorporating cells dispersed in 
3D scaffolds, in order to create functional bone grafts.42  Tissue engineering strategies 
include the use of bioactive factors, osteogenic precursor or stem cells, and natural and 
artificial matrices to support cell attachment, proliferation and differentiation in vivo or, 
alternatively, for in vitro construct development as a preliminary step to implantation.43  
Several groups have demonstrated in vitro development of mineralized constructs by 
combining immature osteoblasts or bone marrow stromal cells with polymeric or ceramic 
scaffolds.44-52  For example, the polymeric scaffolds of poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA) and their copolymers of poly(lactic/glycolic acid) (PLGA) 
have been extensively investigated for tissue engineering applications and support 
osteoblast differentiation, matrix mineralization in vitro and in vivo.53  However, for these 
scaffolds, a severe limitation is that 200-500 µm penetration depths of mineralized tissue 
are typical.54  Correspondingly, in critical size defect models, PLA scaffolds, empty or 
containing osteoprogenitor cells, have failed to close the non-healing defect at 4 weeks.55  
Further illustrating this point, in vitro studies comparing various metals and alloys, as 
well as polymers of PLA, PGA, PLGA, hydroxyapatite, poly(methylmethacrylate), and 
 9
 
poly(hydroxyethyl methacrylate), demonstrated no improvement in cell attachment, 
proliferation collagen synthesis and alkaline phosphatase activity with respect to 
reference materials of tissue culture and glass.56 
Recent studies have demonstrated in vivo bone formation and repair of bone 
defects with scaffolds loaded with osteogenic cells, in particular, marrow-derived 
mesenchymal stem cells.57-63  While these studies establish the potential of tissue 
engineering strategies for bone repair, these cell-base approaches fall short of providing 
mechanically robust, osteoconductive grafting templates, especially for large, non-
healing defects.  A critical limitation of these strategies is the inability of current scaffold 
materials to direct osteogenic cells to proliferate, differentiate and produce robust bone 
tissue.  Thus, there is an essential need for bioactive materials that promote osteoblastic 
differentiation and mineralization for the development of improved grafting templates. 
 
BIOMIMETIC MATERIALS AND BONE REPAIR 
Because cell adhesion to extracellular matrices provides signals critical to 
osteoblast survival, proliferation and differentiation,64 researchers have engineered 
substrates presenting ligands to provide recognition sites in an effort to direct cellular 
adhesion.  These biomimetic substrates have lead to incorporation of the RGD adhesive 
peptide onto surfaces and into scaffolds.  Work in vitro with RGD adhesive peptide 
grafted substrates showed enhancement in cell adhesion and modest improvement in 
mineralization at three weeks.65,66  Furthermore, RGD coating of PLGA scaffolds 
implanted into rat tibial defects enhanced early-stage osteocompatibility and ingrowth.67  
Similarly, matrix metalloproteinase-degradable hydrogels presenting tethered RGD, in 
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conjunction with delivery of bone morphogenetic protein-2, were able to bridge a rat 
cranial critical size defect.68  Taken together, these results suggest that improved adhesive 
interactions at the biomaterial interface could enhance tissue engineered construct 
outcomes. 
 
CELL ADHESION TO ECM PROTEINS  
Cell adhesion to extracellular matrix (ECM) proteins including collagen, laminin, 
fibrinogen, and fibronectin (FN), is essential to such physiological processes as 
development, organogenesis, wound healing and tissue homeostasis.69,70  Cell adhesion 
not only anchors cells, providing tissue structure and integrity and supporting cell 
migration, but also triggers signals that regulate survival, proliferation and 
differentiation.71  Several pathological conditions, including blood clotting defects and 
tumor metastases, involve abnormal adhesion processes.72  Cell adhesion interactions are 
critical to many biomedical and biotechnological applications.73  Cell adhesion to implant 
surfaces via engineered adhesive motifs, proteins pre-adsorbed or proteins adsorbed from 
physiological fluids, is particularly important to host response in biomaterial and tissue 
engineering applications.74,75  Many proteins including albumin, immunoglobulins, 
vitronectin, fibrinogen and FN adsorb onto implant surfaces immediately upon contact 
with physiological fluids and modulate subsequent inflammatory responses.75  For 
example, FN plays an important role in clot formation through its interactions with fibrin 
and activated platelets.76  Adsorbed FN also mediates the attachment and activation of 
neutrophils, macrophages and other inflammatory cells.77  Cell-ECM interactions also 
play a central role in clot retraction, matrix contraction and wound healing.76a  Adhesion 
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to proteins endogenously secreted or adsorbed from serum-containing media provides 
mechanical coupling to the underlying substrate for in vitro applications such as tissue-
engineered constructs, bioreactors and cell culture supports, and activates signaling 
pathways that control cell morphology, proliferation and differentiation.69 
 
INTEGRINS AND FOCAL ADHESIONS 
Cell adhesion to the ECM is a highly regulated process involving cell attachment 
through integrin receptor-ligand binding, cell spreading, and the formation of focal 
adhesions in conjunction with actin stress fibers.  The dominant family of cell adhesion 
receptors mediating attachment to ECM is the integrin receptor family.69  The critical 
physiological importance of integrin receptors and focal adhesion components is 
highlighted by knockout studies in mice where deletions in the genes encoding for 
integrin receptors, focal adhesion components (FAK, vinculin) and ECM ligands (FN, 
laminin) are lethal in the early stages of embryonic development.78  
Integrins are heterodimeric transmembrane receptors consisting of non-covalently 
associated α and β subunits with short cytoplasmic tails and large extracellular regions 
that interact to bind specific amino acid sequences in the ligand.  For example, several 
integrins bind the arginine-glycine-aspartic acid (RGD) recognition sequence present in a 
several ECM proteins such as FN, vitronectin and thrombospondin.79  As seen by rotary 
shadowing electron microscopy, the extracellular, N-terminal portions of both integrin 
subunits contribute to form a globular head domain approximately 8 nm long by 12 nm 
wide with two extended tails about 2 nm thick and 18-20 nm long constituting the 
transmembrane and cytoplasmic tail domains, with the whole complex being 
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approximately 28 nm long.80  Nuclear magnetic resonance and electron microscopy have 
revealed that the cytoplasmic tail of the β subunit binds cytoskeletal and signaling 
proteins, whereas the cytoplasmic tail of the α subunit functions to mask β tail 
interactions until receptor-ligand binding occurs.81-83  X-ray diffraction studies of 
unbound and bound αVβ3 integrin to cyclic RGD ligand has revealed that ligand binding 
induces small changes in the orientation of the α chain with respect to the β chain.84  In 
contrast, molecular electron microscopy of α β5 1 binding to FN fragments reveal much 
larger conformational differences.85 
 Integrins connect the ECM to the cytoskeleton to anchor cells, providing tissue 
structure and integrity.  Integrins also function as signal transducers, transmitting 
information contained in the ECM to intracellular signaling pathways and cytoskeletal 
rearrangements that control survival, proliferation and differentiation.86  This process is 
termed “outside-in signaling”.87  Conversely, “inside-out signaling” consists of a 
conformational change in integrin subunits to an activated state in order to modulate 
ligand binding affinity and cellular adhesion.87 
Upon binding ligand, integrins cluster together to form focal adhesions, the sites 
of greatest cell adhesion and closest points of contact between the cell membrane and the 
ECM substrate (Figure 2.1).88  Focal adhesions are complexes that consist of not only 
cell-surface receptors and cytoskeletal proteins, but also include abundant signaling 
molecules.89  Upon integrin binding to FN, bound receptors rapidly associate with the 
actin cytoskeleton and cluster together giving rise to focal adhesions containing 
cytoplasmic structural proteins such as vinculin, talin and α-actinin, and signaling 
molecules including src, FAK and paxillin, as well as transmembrane proteoglycans.90  
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Focal adhesions are crucial to the adhesion process, directing growth and 
differentiation.91-93 
 
FIBRONECTIN- AN ESSENTIAL ECM COMPONENT 
The ECM consists of a dynamic network of heterogeneous macromolecules 
secreted by many cell types to serve tissue-specific functions.94  By supporting cell 
adhesion and storing growth factors, the ECM provides structure and signals vital for 
cells, playing an active and complex role in regulation, influencing development, 
migration, proliferation, shape and function.  The ECM glycoprotein FN, the first cell 
adhesion protein identified,95 has been investigated extensively.96  The physiological 
importance of FN is demonstrated by the embryonic lethality of the FN-gene deletion.97  
FN has been shown to be involved in numerous physiological and pathological processes 
including tissue and organ development, tissue homeostasis, hemostasis, wound healing 
and cancer metastasis.96  Cellular interactions with FN are primarily mediated by 
integrins.  Integrin binding to FN plays a critical role in the survival, proliferation and 
differentiation of numerous cell types, including fibroblasts, myoblasts, chondrocytes and 
keratinocytes.98  For example, α5β1 integrin-mediated adhesion to FN regulates osteoblast 
survival and expression of osteoblast-specific genes and matrix mineralization, as well as 
myoblast differentiation, in vitro.64,115  
 Plasma FN is a dimer of two polypeptide chains of approximately 220 kDa each, 
covalently linked by two interchain disulfide bridges close to the C-terminus (Figure 2.2).  
Each polypeptide chain is composed of a series of flexible, repeating functional domains 
of type I, II or III.  The central integrin-binding site in FN localizes to the RGD motif in 
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the 10th type III repeat.99  Additional integrin-binding domains include the PHSRN site in 
the 9th type III repeat, which in conjunction with the RGD site, binds synergistically to 
several integrins.99  FN is secreted by many cell types in different splice-variants and is 
expressed in most tissues and body fluids.94  FN is synthesized as soluble dimers which 
can then undergo cell-mediated polymerization into insoluble fibrillar networks by 
numerous cell types including fibroblasts, chondrocytes, myoblasts, smooth muscle cells, 
endothelial cells and epithelial cells.96  Some cell types synthesize and secrete FN, but do 
not assemble fibrils, including macrophages, activated neutrophils and activated T-
lymphocytes.100   
 
CELL ADHESION TO BIOMATERIAL SURFACES 
Numerous studies have shown that surface properties influence the type, amount 
and conformation of adsorbed proteins.101-104  For example, hydrophilic ethylene glycol-
terminated SAMs resist protein adsorption and consequently, cell adhesion, as opposed to 
the hydrophobic hexadecanethiolate-functionalized SAM that supports protein 
adsorption, cell adhesion and spreading.105  The conformation, or three-dimensional 
structure, of many proteins including FN, is sensitive to surface chemistry.77,106  Upon 
adsorption onto natural and synthetic substrates, FN undergoes conformational changes 
as demonstrated by electron spin resonance,107 infrared spectroscopy,108 fluorescence 
polarization,109 rotary shadowing,110 and antibody binding.111  Changes in FN 
conformation alter its ability to support cell adhesion and spreading.111-114  Substrate-
dependent changes in FN conformation have been shown to alter integrin binding and 





While the examples provided illustrate progress in engineering of orthopedic 
implants, there is clearly a need to further the development of improved implant surfaces 
and bone graft materials.  Therefore, we propose that a mechanistic understanding of the 
factors governing biological responses to surfaces in vitro and in vivo is necessary for the 
continued development of materials to repair and regenerate lost tissue function.  This 
project analyzes osteoblast adhesion and differentiation as a function of the underlying 
surface chemistry in an effort identify chemistries that modulate the activity of the ECM 
protein FN to control integrin receptor binding, which in turn directs cell function.  
Engineered surfaces that direct cell function could improve osteoconductive scaffolds by 
not just simply allowing mineralized tissue to penetrate the scaffold, but by inducing 
osteoblastic differentiation within the scaffold itself.  Previous studies have examined 
osteoblast function grown on various materials, including metals, polymers and 
ceramics,56 demonstrating that different substrates support different levels of expression 
of the osteoblastic phenotype.  However, these studies do not provide an understanding of 
the underlying mechanisms of the cell-matrix-surface interactions due to poorly defined 
substrates and the complex nature of these interactions.  In an effort to understand the 
fundamental role of the underlying substrate, recent work has investigated osteoblast 
function on surfaces with well-defined chemistries and biomimetic surfaces.62,116-118  
Although these studies indicate that substrate chemistry and RGD peptides influence 
osteoblast function, and that cell adhesion is important, the cell-matrix-surface 
interactions were not analyzed in depth.  Understanding these adhesive interactions is 
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critical to the rational design of surfaces, as recent studies have shown that modulation of 
specific adhesive interactions controls cell function.115,119-121 
The approach of controlling cell receptor-ligand interactions through underlying 
substrata represents a versatile method to manipulate cellular responses for biomaterial 
and tissue engineering applications.  By focusing on a bioengineering analysis of 
integrin-FN binding as a function of the underlying substrate, a fundamental framework 
is established for the rational design of substrates to direct cell function.  Although this 
project deals with model surfaces, the understanding provided by this analysis may be 
useful in the engineering of surface properties for bone tissue repair and regeneration.  
The results from this project identified surface chemistries that modulate FN 
conformation to promote specific integrin receptor binding and osteoblast differentiation.  
These chemistries can then be incorporated into implant surface coatings or polymer 
backbones of three-dimensional scaffolds, potentially addressing limitations in the 

















Figure 2.1.  Diagram of a focal adhesion showing the clustering of integrins binding to 
surface-adsorbed FN.  Focal adhesions are in close apposition to the substrate and the 
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Figure 2.2.  Schematic model of FN.   This diagram illustrates the linear organization of 
repeating structural subunits I, II and III, the amine and carboxy termini as well as the 
disulfide-bridge site of dimerization.  Shown are fibrin, collagen and FN (self-assembly) 
binding domains, as well as the central cell binding domain (CCBD) that includes the 
RGD binding motif and the PHSRN synergy site.  Also shown are the heparin and fibrin 
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  CHAPTER 3: Quantitative Methods for Analysis of Integrin Binding and Focal Adhesion Formation on Biomaterial Surfaces 
 
QUANTITATIVE METHODS FOR ANALYSIS OF INTEGRIN BINDING AND 
FOCAL ADHESION FORMATION ON BIOMATERIAL SURFACES* 
 
SUMMARY 
Integrin binding and focal adhesion assembly are critical to cellular responses to 
biomaterial surfaces in biomedical and biotechnological applications.  While 
immunostaining techniques to study focal adhesion assembly are well-established, a crucial 
need remains for quantitative methods for analyzing adhesive structures.  We present 
simple yet robust approaches to quantify integrin binding and focal adhesion assembly on 
biomaterial surfaces.  Integrin binding to fibronectin and a RGD-containing synthetic 
peptide was quantified by sequentially cross-linking integrin-ligand complexes via a water-
soluble homo-bifunctional cross-linker, extracting bulk cellular components in detergent, 
and detecting bound integrins by ELISA.  Focal adhesion components (vinculin, talin, 
α−actinin) localized to adhesion plaques were isolated from bulk cytoskeletal and 
cytoplasmic components by mechanical rupture at a plane close to the basal cell surface 
and quantified by Western blotting.  These approaches represent simple and efficient 
methodologies to analyze structure-function relationships in cell-material interactions.   
 
INTRODUCTION 
Cell adhesion to biological and synthetic surfaces is critical to biomedical and 
biotechnological applications.1-5  For example, adhesion to proteins adsorbed onto 
implant surfaces, including immunoglobulins, vitronectin, fibrinogen and fibronectin 
 * Keselowsky, B.G. and García, A.J. Biomaterials. (in press).  
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(FN), is important to host and cellular responses in biomaterial and tissue engineering 
applications.6,7  In many instances, cell adhesion to extracellular proteins is mediated by 
the integrin family of cell surface receptors.  In addition to anchoring cells and supporting 
spreading and migration, integrins trigger signaling cascades that regulate cell survival, 
proliferation and differentiation.8,9  Upon binding their extracellular ligand, integrins 
cluster to form focal adhesions, complexes containing structural and signaling molecules 
that participate in both mechanical and signaling capacities crucial to the adhesion 
process.10,11  Over the last decade, it has become evident that the structure, composition, 
and distribution of focal adhesion components play central roles in the regulation of 
adhesive processes.12  This is particularly important in the context of cell-biomaterial 
interactions as different materials elicit diverse adhesive interactions that modulate cell 
function.13-17  While immunostaining techniques to study focal adhesion assembly are 
well-established, a crucial need remains for quantitative methods for analyzing integrin 
binding and focal adhesion assembly.  These methodologies are essential to structure-
function analyses of cell-material interactions.  In the present chapter, we describe two 
robust approaches to quantify integrin binding and focal adhesion assembly on 
biomaterial surfaces. 
 
MATERIALS AND METHODS 
Cells and reagents 
Human plasma FN, Dulbecco’s phosphate buffered saline (DPBS: 137 mM NaCl, 
2.7 mM KCl, 4.3 mM Na2HPO4⋅7H2O, 1.5 mM KH2PO4, 0.9 mM CaCl2⋅2H2O, 1 mM 




(Carlsbad, CA).  Fetal bovine serum was purchased from Hyclone (Logan, UT).  The 
cross-linkers bis(2-(sulfo-succinimidooxycarbonyloxy)ethyl)sulfone (sulfo-BSOCOES) 
and 3,3’-dithiobis(sulfosuccinimidylpropionate) (DTSSP) were acquired from Pierce 
Chemical (Rockford, IL).  Monoclonal antibodies against paxillin (Z035) and vinculin 
(V284) were obtained from Zymed Laboratories (San Francisco, CA) and Upstate (Lake 
Placid, NY), respectively.  Alexa Fluor 488-conjugated anti-rabbit and anti-mouse IgG 
antibodies were acquired from Molecular Probes (Eugene, OR), while biotinylated anti-
rabbit IgG and alkaline phosphatase-conjugated anti-rabbit IgG antibodies were 
purchased from Jackson ImmunoResearch (West Grove, PA).  Bovine serum albumin, 
Fibronectin-Like Engineered Protein Polymer (ProNectinTM), anti-talin (8D4) and anti-α-
actinin (BM-75.2) monoclonal antibodies, alkaline phosphatase-conjugated anti-biotin 
antibody (BN-34), and all other chemical reagents were obtained from Sigma (St. Louis, 
MO).   
MC3T3-E1 cells were obtained from the RIKEN Cell Bank (Tokyo, Japan).  Prior 
to seeding on FN-coated substrates, MC3T3-E1 cells were maintained in α-modified 
Eagle’s medium supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin and passaged every 2 days using standard techniques. 
 
Integrin binding analysis  
Tissue culture-treated polystyrene 48-well plates were coated with a range of 
coating concentrations of either FN or ProNectinTM for 30 minutes and then blocked in 




culture dishes with 0.5% trypsin + 0.53 mM EDTA for 3 min and resuspended in serum-
containing media.  After washing and resuspending in DPBS + 2 mM dextrose, cells 
were seeded onto substrates at 500 cells/mm2 under serum-free conditions (2 mM 
dextrose in DPBS) for 1 hour.  Sulfo-BSOCOES or DTSSP (in cold DPBS, 1mM final 
concentration) was then added for 30 minutes to cross-link integrins to their bound 
ligand.  Unreacted cross-linker was quenched for 10 minutes by the addition of 50 mM 
Tris in 2 mM dextrose-DPBS.  Uncross-linked cellular components were then extracted 
in 0.1% SDS + 350 µg/ml phenylmethylsulfonyl fluoride (PMSF) in cold DPBS.   
Cross-linked integrins were quantified by ELISA.  After rinsing three times with 
PBS, samples were incubated in blocking buffer (5% serum in DPBS) for 1 hour, and 
cross-linked integrins were probed with integrin-specific primary antibodies (2.5 µg/mL) 
in blocking buffer for 1 hour at 37°C.  After washing, samples were incubated in alkaline 
phosphatase-conjugated secondary antibody (0.6 µg/mL) in blocking buffer for 1 hour at 
37°C.  After washing in DPBS and diethanolamine buffer (10 mM diethanolamine, 0.5 
mM MgCl2, pH 9.5), 5-methyl umbelliferyl phosphate (60 µg/ml in diethanolamine 
buffer + 50 mM Na2CO3, pH 9.5) was incubated for 45 minutes at 37°C in the dark.  
Reaction supernatants were transferred to clean black 96-well plates and the resulting 
fluorescence (365 nm excitation/450 nm emission) was read in a HTS 7000 Plus 
BioAssay microwell plate reader (Perkin Elmer, Norwalk, CT).  For each sample, relative 
fluorescence intensity, which is proportional to the amount of antibody bound, was 
determined as a function of ligand density.  In parallel samples, cross-linked integrins 
were visualized via immunofluorescence staining by incubating in Alexa Fluor 488-




antibody.  Additional samples were processed for standard immunofluorescence staining 
for comparison to cross-linked samples.  Cells were permeabilized for 5 min in 0.5% 
Triton X-100 in 50 mM Tris (pH 6.8), 50 mM NaCl, 150 mM sucrose, 3 mM MgCl2 
supplemented with protease inhibitors (10 µg/mL PMSF, leupeptin, and aprotinin) and 
then fixed in cold 3.6% formaldehyde (in DPBS) for 5 min.  After blocking with 5% 
serum, cultures were incubated in primary and secondary antibodies for integrins as 
described above. 
 
Focal adhesion assembly analysis 
Tissue culture-treated polystyrene 35 mm dishes were coated with either 0.1 or 10 
µg/mL FN (corresponding to 0.3 ng/cm2 and 320 ng/cm2 adsorbed FN) for 30 min and 
blocked with 1% hd-BSA for 30 min.  Cells were detached as described above and 
seeded onto FN-coated substrates at 400 cells/mm2 in 10% serum for 1 hour. After 
rinsing in DPBS, buffer was aspirated from cell cultures and a dry nitrocellulose sheet 
(PROTRAN BA85, Schleicher & Schuell) was overlaid onto the cells for 1 min.  Cells 
were then cleaved by rapidly by lifting the nitrocellulose sheet with tweezers, and cleaved 
surfaces were rinsed in DPBS with protease inhibitors (10 µg/mL PMSF, leupeptin, and 
aprotinin) and scraped in Laemmli sample buffer (100 µl).  Recovered proteins were 
analyzed by Western blotting as detailed previously.18  DNA was solubilized from 
corresponding nitrocellulose sheets and quantified by SYBR Green (Molecular Probes, 
OR) incorporation to normalize for cell numbers.  Parallel plates were cleaved and 




blotting analyses.  For comparison with standard techniques, cells were permeabilized in 
Triton X-100 buffer, fixed in formaldehyde, and immunostained for focal adhesion 
proteins as detailed above. 
 
RESULTS 
Integrin binding analysis  
Integrin binding to adsorbed adhesive proteins (FN or ProNectinTM) was 
quantified using a modification of the cross-linking/extraction biochemical method 
developed by our group.13,18  This scheme (Fig 3.1A) uses a water-soluble, cell 
membrane-impermeable, homobifunctional cross-linker (equivalent results have been 
obtained for sulfo-BSOCOES [13Å spacer arm] and DTSSP [12Å spacer arm]) to couple 
primary amine groups in the integrin and adhesive ligand.  Taking advantage of the fact 
that most adhesive matrix proteins, including FN, are resistant to mild detergent 
extraction, the bulk of cell components (including unbound receptors) is then extracted 
with 0.1% SDS, leaving behind matrix proteins adsorbed to the substrate and their 
associated integrins.  Bound integrins can then be easily visualized by 
immunofluorescence staining or quantified by ELISA as shown here.  Alternatively, 
bound integrins can be recovered by cleaving the cross-linking and quantified by Western 
blotting.13,18  Control experiments have previously demonstrated that these chemical 
reagents will specifically cross-link bound integrins.  Only FN-binding integrins are 
detected when cells are seeded on FN, while only laminin-binding integrins are detected 




receptors, are cross-linked to FN,20 demonstrating that the cross-linking is specific for 
bound integrins. 
Immunofluorescence staining for integrin subunit α5 on cells plated on FN-coated 
substrates was performed for samples prepared by conventional (TritonX-100 extracted/ 
formaldehyde fixed) and cross-linking/extraction protocols (Fig. 3.1B).  This analysis 
showed equivalent localization of α5β1 integrin to focal adhesions for both treatments, 
demonstrating that the cross-linking/extraction method does not alter integrin 
distribution.  Differences in staining intensity resulted from differences in antibody 
accessibility to the integrin.  A clear advantage of the cross-linking/extraction method for 
immunofluorescence staining is the absence of non-specific nuclear staining, allowing 
visualization of receptor binding across the entire spread area.   
In order to demonstrate the ability of this technique to quantify integrin binding, 
the relative levels of α5β1 and αvβ3 integrin bound to adsorbed FN and ProNectinTM were 
measured by ELISA (Fig. 3.2).  Both integrins bind to the RGD motif in the 10th type III 
repeat of FN, but α5β1 binding also requires the PHSRN synergy site in the 9th type III 
repeat.21,22  ProNectinTM is a protein polymer presenting multiple RGD loop repeats that 
supports αvβ3, but not α5β1, binding.22  Dose-dependent increases in α5β1 binding to 
adsorbed FN were detected, while binding of αvβ3 was minimal.  This result is consistent 
with antibody-blocking experiments demonstrating that α5β1 provides the dominant 
adhesion mechanism in this cell model.14  In contrast, ProNectinTM-coated substrates 
supported high levels of αvβ3 integrin binding and background levels of α5β1 integrin 
binding, in accordance with the requirement of the PHSRN site for α5β1 integrin binding.  




relationship for a simple receptor-ligand interaction, thereby allowing estimation of 
effective binding affinity.  These measurements can be used for rigorous comparisons 
among experimental treatments.  For example, we have recently shown that changes in 
the structure of adsorbed FN modulate integrin binding affinity.14  Taken together, these 
results demonstrate the ability of this cross-linking/extraction technique to quantify 
integrin binding to adsorbed extracellular matrix proteins. 
 
Focal adhesion assembly analysis 
  Quantification of focal adhesion components localized to adhesive plaques 
requires the isolation of these adhesive cell structures from bulk cellular components.  
We have modified the wet-cleaving technique developed by Brands and Feltkamp23 to 
expose the cytoplasm of adherent cells in order to quantify focal adhesion assembly (Fig. 
3.3A).  A nitrocellulose sheet is overlaid onto cells to irreversibly bind protein and 
membrane components on the apical surface.  After a specified overlay time, the 
nitrocellulose sheet is rapidly removed to mechanically rupture the cells, leaving basal 
cell structures anchored to the underlying extracellular matrix.  These components can 
then be visualized by immunostaining or recovered for biochemical analyses.  By 
controlling the cleaving conditions (overlay time and liquid volume present at the 
cell/membrane interface), cells can be ruptured at different planes relative to the 
underlying substrate.  Using a dry nitrocellulose sheet and 1-min overlay time, spread 
cells are cleaved at a rupture point close to the adhesive substrate.  These cleaving 
conditions produced similar results in spread fibroblasts (data not shown), but may have 




Immunostaining for vinculin, a marker of mature focal adhesions, demonstrated 
equivalent distribution and intensities of vinculin recruitment for samples prepared by 
conventional (Triton X-100 extraction/formaldehyde fixation) and wet-cleaving 
approaches (Fig. 3.3B).  Similar results were obtained for other focal adhesion 
components, including integrin, talin, and α-actinin.  These results demonstrate that the 
wet-cleaving technique isolates basal membranes containing focal adhesion structures 
without introducing mechanical/staining artifacts.  In order to demonstrate the ability of 
this technique to quantify focal adhesion assembly, cells were plated on substrates coated 
with low or high FN densities, wet-cleaved, and immunostained for focal adhesion 
components (Fig. 3.4A).  As expected, higher densities of vinculin, talin, and β1 integrin 
subunit were detected on high FN substrates than on low FN substrates.  These results 
were confirmed by Western blotting analyses on cleaved cells showing 2-, 1.3-, 5-, and 
1.4-fold increases in vinculin, talin, β1 integrin subunit, and α-actinin localization on high 
FN compared to low FN substrates, respectively (Fig. 3.4B).  Taken together, these 
results validate this wet-cleaving protocol to quantify focal adhesion assembly.  
 
DISCUSSION 
Quantification of integrin binding and focal adhesion assembly is critical to 
structure-function analyses of cell-material interactions.  While immunostaining 
techniques provide relatively easy approaches to visualize integrin binding and focal 
plaque assembly, these approaches are limited in their ability to quantify adhesive 
structures.  In the present paper, we describe two robust yet simple protocols for the 




sensitive and reproducible measurements that can be used to examine functional 
relationships in cell adhesive interactions as shown here and other reports from our 
group.14,24  Furthermore, these techniques are applicable to analyses on a broad range of 
material substrates. 
The cross-linking/extraction protocol was originally developed by Boettiger and 
colleagues to visualize bound integrins19 and subsequently modified by García and 
Boettiger to quantify integrin binding via Western blotting.13,18  In the present work, we 
extend this approach to ELISA-based detection to provide rapid, high-throughput, simple 
and sensitive detection of integrin binding.  Furthermore, we demonstrate that this 
technique can be used to quantify integrins bound to natural (FN) and synthetic 
(ProNectinTM) ligands.  This detection protocol offers considerable advantages over 
quantitative image analysis-based microscopy methods, which are significantly more 
time- and skill-intensive and require specialized equipment.  Finally, it is important to 
note that this technique relies on a labile cross-linker of fixed spacer arm and chemical 
reactivity (primary amines) and, while we have demonstrated applicability to several 
integrin-ligand pairs, application of this technique to other adhesive systems requires 
careful validation.  We strongly recommend using integrin binding to FN as a positive 
control or standard for comparison. 
We also describe a modified wet-cleaving technique to quantify focal adhesion 
assembly.  This method relies on mechanically rupturing the cell to isolate the basal cell 
membrane and associated focal adhesions from bulk cell components.  To quantify focal 
adhesion components, Western blotting was chosen instead of ELISA-based detection 




plaque structures.  This technique is straightforward compared to image-based 
microscopy analyses which involve considerable time and computational costs and 
sophisticated experimental systems.  The wet-cleaving approach contrasts with 
conventional biochemical techniques that rely on sequential extraction with detergents of 
varying strength to segregate cytoskeletal components from the cytosolic fraction.25  In 
fact, Plopper and Ingber demonstrated that wet-cleaving methods are more 
effective/selective than detergent extraction approaches in isolating focal adhesion 
components from bulk cell constituents.26  These investigators also described a combined 
biochemical and mechanical isolation technique using ligand-coated magnetic micro-
beads.26  This combined approach, however, is more time- and skill-intensive and is not 
easily applied to different material formulations.  In contrast, the modified wet-cleaving 
method described here can be used on a variety of substrates.  Finally, we recommend 
that this technique be used in combination with immunostaining to provide additional 
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Figure 3.1.  Analysis of integrin binding via cross-linking/extraction method. (A) Cross-
linking/extraction scheme consisting of (i) integrin binding to adsorbed adhesive protein,
(ii) cross-linking of bound integrins to the underlying matrix and (iii) detergent extraction
to isolate bound integrins for (iv) detection by immunostaining or ELISA. (B)
Comparison of cross-linking/extraction method to Triton X-100 permeabilization,
showing similar α5β1 integrin localization to focal adhesions (arrows), as well as
demonstrating the greater accessibility of bound integrins to immunostaining with the
cross-linking/extraction method. Scale bar (left panel) indicates 10 µm.  41
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 Figure 3.2.  Quantitative analysis of integrin binding via cross-linking/extraction method. Bound integrins α5β1 and αVβ3 plotted as a function of ligand coating concentration (FN 
or ProNectinTM), showing specificity for bound integrins and dose-dependent increases 
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Figure 3.3. Analysis of focal adhesion formation by wet-cleaving method. (A) Wet-
cleaving scheme, consisting of (i) overlaying nitrocellulose onto adherent cells, (ii) non-
specific adhesion of membrane-bound proteins to the nitrocellulose, (iii) mechanical 
cleaving of cells in order to isolate focal adhesion complexes in a plane close to the 
underlying substrate and (iv) detection by immunostaining or Western blotting. (B) 
Comparison of wet-cleaving method to Triton X-100 permeabilization, showing similar 
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Figure 3.4. Quantification of focal adhesion assembly by wet-cleaving method, showing 
differences in vinculin, talin, β1 integrin and α-actinin localization to focal plaques 
between low and high FN densities by (A) immunostaining and (B) Western blotting. 
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                                                 CHAPTER 4: SURFACE CHEMISTRY MODULATES FIBRONECTIN CONFORMATION AND DIRECTS INTEGRIN BINDING AND SPECIFICITY TO CONTROL CELL ADHESION 
 
SURFACE CHEMISTRY MODULATES FIBRONECTIN CONFORMATION 




Integrin-mediated cell adhesion to proteins adsorbed onto synthetic surfaces 
anchors cells and triggers signals that direct cell function.  In the case of fibronectin (FN), 
adsorption onto substrates of varying properties alters its conformation/structure and its 
ability to support cell adhesion.  In the present study, self-assembled monolayers (SAMs) 
of alkanethiols on gold were used as model surfaces to investigate the effects of surface 
chemistry on FN adsorption, integrin binding and cell adhesion.  SAMs presenting 
terminal CH3, OH, COOH and NH2 functionalities modulated adsorbed FN conformation 
as determined through differences in the binding affinities of monoclonal antibodies 
raised against the central cell-binding domain (OH > COOH = NH2 > CH3).  Binding of 
α5β1 integrin to adsorbed FN was controlled by SAM surface chemistry in a manner 
consistent with antibody binding (OH > COOH = NH2 > CH3), while αV integrin binding 
followed the trend: COOH >> OH = NH2 = CH3, demonstrating α5β1 integrin specificity 
for FN adsorbed onto the NH2 and OH SAMs.  Cell adhesion strength to FN-coated 
SAMs correlated with α5β1 integrin binding (OH > COOH = NH2 > CH3), and 
experiments with function-perturbing antibodies demonstrated that this receptor provides 
the dominant adhesion mechanism in this cell model.  This work establishes an 
experimental framework to analyze adhesive mechanisms controlling cell-surface 
interactions and provides a general strategy of surface-directed control of adsorbed 
 * Keselowsky, B.G., Collard, D.M. and García, A.J.  J Biomed Mat Res. 66A:247-259. (2003). 
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Cell adhesion to synthetic surfaces is critical to numerous biomedical and 
biotechnological applications.1,2  Cell adhesion to proteins adsorbed onto implant 
surfaces is particularly important to host responses in biomaterial and tissue engineering 
applications.1,3,4  Many proteins, including immunoglobulins, vitronectin, fibrinogen and 
fibronectin (FN), adsorb onto implant surfaces immediately upon contact with 
physiological fluids and modulate subsequent inflammatory responses.5-7  For example, 
adsorbed adhesive proteins mediate the attachment and activation of neutrophils, 
macrophages and other inflammatory cells.8,9  For in vitro applications such as tissue-
engineered constructs, bioreactors and cell culture supports, cell adhesion to pre-adsorbed 
proteins, proteins adsorbed from serum-containing media, endogenous proteins secreted 
by the cells, or engineered bioadhesive motifs, provides mechanical coupling to the 
underlying substrate and triggers signals that direct subsequent cellular responses 
including proliferation and differentiation.10-12  Consequently the engineering of surfaces 
to control cell adhesion represents an active area of biomaterials research. 
Because of the central role of protein adsorption in inflammation, clotting and cell 
adhesion, extensive research efforts have focused on the analysis of protein adsorption to 
synthetic surfaces.  These studies have shown that the type, quantity and conformation 
(activity) of adsorbed proteins are influenced by the underlying substrate.  Surface 




energy, roughness and chemistry.13-18  For example, FN adsorption to different surfaces 
alters the structure of the protein and influences cell adhesion, spreading and 
migration.13,19,20  Although these studies have provided insights into the relationships 
between surface properties and protein adsorption, many of these experimental systems 
suffer either from a lack of surface homogeneity or indeterminable surface properties.  
For instance, polymeric surfaces can undergo conformational rearrangements in response 
to environmental conditions and can exhibit differences in surface roughness and 
topology depending on processing or surface modifications.21,22  These factors can 
obscure correlations between biological markers (e.g. protein adsorption, cell spreading) 
and surface properties, thus complicating interpretation of these fundamental interactions.  
To address these limitations, recent work has focused on model substrates with well-
controlled properties.23,24,60  In particular, self-assembled monolayers (SAMs) of 
alkanethiols on gold have provided a useful model system to systematically investigate 
the effects of surface chemistry without altering other surface properties such as 
roughness.  Long-chain, functionally-terminated alkanethiols (HS-(CH2)n-X, n ≥ 10) 
adsorb from solution onto gold surfaces through gold-sulfur coordination at the chain 
head and the alkyl chains pack together to form stable, well-packed and ordered 
monolayers.25-27  Once assembled, the end group X comprises a uniform interface of 
designated surface chemistry (Figure 4.1A).  SAMs of alkanethiols on gold, therefore, 
represent a versatile and robust model system to study protein adsorption and cell 
adhesion.   
Recent studies using alkanethiol SAMs have demonstrated that surface chemistry 




underlying mechanisms controlling these cell-protein-surface interactions remain poorly 
understood, especially in terms of the adhesion receptors mediating the observed cellular 
responses.  A fundamental understanding of these adhesive interactions is critical to the 
rational design of surfaces, as recent work has shown that modulation of specific 
adhesive interactions directs cell signaling to control higher order cellular programs such 
as proliferation and differentiation.33,34 
Cell adhesion to extracellular matrix proteins is primarily mediated by the integrin 
family of cell-surface receptors.10  Integrins not only anchor cells, supporting cell 
spreading and migration, but also trigger signals that regulate survival, proliferation and 
differentiation.33,35-40  In the present work, using SAMs presenting well-defined 
chemistries, we demonstrate that surface-dependent conformational differences in 
adsorbed FN modulate integrin binding to potentiate cell adhesion.  These results 
contribute to our understanding of mechanisms controlling cell-surface interactions. 
 
MATERIALS AND METHODS 
Reagents 
Human plasma FN and other tissue culture reagents were obtained from Life 
Technologies (Grand Island, NY).  Fetal bovine serum was purchased from Hyclone 
(Logan, UT).  Bovine serum albumin, 5-methyl umbelliferyl phosphate, and all other 
chemical reagents were obtained from Sigma Chemical (St. Louis, MO).  Bis(2-
(sulfosuccinimidooxycarbonyloxy)ethyl)sulfone (sulfo-BSOCOES) cross-linker was 
purchased from Pierce Chemical (Rockford, IL).  Mouse monoclonal HFN7.1 and 




the Developmental Studies Hybridoma Bank (Iowa City, IA) and Chemicon (Temecula, 
CA), respectively.  Rabbit polyclonal antibodies against murine integrin subunits were 
purchased from Chemicon.  Calcein-AM and Alexa Fluor 488-conjugated goat anti-rabbit 
IgG antibody were acquired from Molecular Probes (Eugene, OR), while alkaline 
phosphatase-conjugated donkey anti-rabbit IgG antibody was purchased from Jackson 
ImmunoResearch (West Grove, PA).  Bolton-Hunter Reagent for FN iodination was 
purchased from NEN Life Science Products (Boston, MA). 
 
Alkanethiols and Self-Assembled Monolayers 
 Alkanethiols 1-dodecanethiol (CH3-(CH2)11-SH), 11-mercapto-1-undecanol (HO-
(CH2)11-SH) and 11-mercaptoundecanoic acid (HOOC-(CH2)10-SH) were purchased from 
Aldrich Chemical (Milwaukee, WI) and used as received.  The amine-terminated 
alkanethiol, 12-amino-1-mercaptododecane (H2N-(CH2)12-SH) was synthesized and 
purified following the scheme of Sayre and Collard41, and validated by 1H NMR.  
Assembled SAMs of their respective alkanethiols are referred to hereafter as CH3, OH, 
COOH and NH2 SAMs, respectively.  Gold-coated glass coverslips were used as SAM 
substrates for SAM characterization, FN adsorption studies, and immunofluorescence 
staining of integrins.  Gold-coated glass chamber slides (16-well Lab-Tek Chamber 
Slides, Nalge Nunc International, Naperville, IL) were used as SAM substrates for FN 
conformation, integrin binding quantification, and cell adhesion studies.  Both gold-
coated substrates were prepared by sequential deposition of optically transparent films of 
titanium (10 nm) and gold (20 nm) onto clean glass supports.  An electron beam 




chamber base-pressure between 1-2 x 10-6 torr with a deposition rate of 2 Å/second.  
Freshly prepared gold surfaces were immersed in ethanolic alkanethiol solutions (1 mM 
in absolute ethanol), and SAMs were allowed to assemble for 12 hours.  Before use, 
SAMs were rinsed in ethanol, dried with N2, and allowed to equilibrate in Dulbecco’s 
phosphate buffered saline (DPBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4⋅7H2O, 
1.5 mM KH2PO4, 0.9 mM CaCl2⋅2H2O, 1 mM MgCl2⋅6H2O, pH = 7.4) for 15 minutes 
prior to incubation in FN solutions. 
 Surfaces were characterized by contact angle and X-ray photoelectron 
spectroscopy (XPS) measurements.  Ambient air-water-substrate contact angle 
measurements (5 µL pure, de-ionized H2O) were taken with a Rame-Hart (Mountain 
Lakes, NJ) model # 100-00 goniometer fitted with a digital camera and analyzed using 
in-house image analysis software.  Multi-angle XPS data was obtained at 30° and 70°, 
measured from the plane of the substrate, using a PHI Model ESCA 1600 system 
operating below 5×10-9 torr with a 350 W monochromatic Alkα source of 1486.7 eV.  
Electron pass energy of 11.75 eV was used to analyze the regions of interest and curve 
fitting was performed on each spectral region to calculate atomic percentages. 
 
FN Adsorption to SAMs 
FN adsorption onto SAMs was quantified as a function of FN coating 
concentration using 125I-FN.  FN was iodinated with the Bolton-Hunter Reagent as 
described previously.42  Briefly, the Bolton-Hunter Reagent benzene solvent was 
evaporated with a gentle stream of N2 and 100 µg FN (10 µg/µl in 0.1 M sodium borate, 




reaction was stopped with 50 µl of 0.2 M glycine in 0.1 M sodium borate (pH = 8.5).  
Labeled FN (125I-FN) was separated from glycine conjugate and hydrolysis products by 
size exclusion chromatography in a Sephadex G-25 column (Sephadex column was 
blocked in 1% bovine serum albumin overnight prior to use).  Fractions were collected 
and examined for radioactive counts.  Fractions containing 125I-FN were pooled and 
stored at 4°C.  Specific activity (1.5 x 106 cpm/µg) of 125I-FN was determined using a 
COBRA II Auto Gamma counter (Packard Bioscience, Meridien, CT), in conjunction 
with the NanoOrange Protein Quantification Kit (Molecular Probes).  Control adsorption 
experiments with different ratios of labeled to unlabeled FN demonstrated that the 
iodination procedure did not alter FN adsorption behavior. 
SAMs were coated for 30 minutes at room temperature with 125I-FN mixed with 
unlabeled FN and diluted in Dulbecco’s phosphate-buffered saline (DPBS) to a range (1-20 
µg/ml) of coating concentrations and subsequently blocked for 30 minutes in 1% heat-
denatured bovine serum albumin (hd-BSA).  Adsorbed 125I-FN was quantified and 
radioactive counts (cpm) were converted to adsorbed FN surface densities (ng/cm2). 
 
FN Conformation on SAMs 
The conformation of FN adsorbed onto SAMs was examined over a range of FN 
surface densities using monoclonal antibodies, 3E3 and HFN7.1, in a normalized enzyme-
linked immunosorbent assay (ELISA).33  SAMs were coated with FN for 30 minutes, 
blocked in 1% hd-BSA for 30 minutes, and incubated with FN-specific antibodies (3E3: 
1/4000 dilution; HFN7.1: 1/10,000 dilution) in blocking buffer (DPBS + 0.25% BSA + 




were incubated in alkaline phosphatase-conjugated anti-mouse IgG antibody (1/1000 
dilution) in blocking buffer for 1 hour at 37 °C.  After three washes in blocking buffer, 5-
methyl umbelliferyl phosphate (60 µg/ml in diethanolamine, pH = 9.5) was incubated for 
45 minutes at 37 °C in the dark.  Reaction supernatants were transferred to clean black 96-
well plates and the resulting fluorescence (365 nm excitation/450 nm emission) was read in 
a HTS 7000 Plus BioAssay microwell plate reader (Perkin Elmer, Norwalk, CT).  For each 
antibody, relative fluorescence intensity, which is proportional to the amount of antibody 
bound, was determined as a function of FN surface density. 
 
Cell Model to Examine Adhesive Interactions 
We chose the MC3T3-E1 osteoblast-like cell line to investigate the effects of 
surface chemistry on integrin binding.  This immature osteoblast-like cell line expresses 
multiple FN-binding integrins, including α5β1 and αvβ3, and previous work in our group 
has shown that integrin binding to FN is critical for osteoblastic gene expression and 
matrix mineralization in these cells.34  Cells were obtained from the RIKEN Cell Bank 
(Tokyo, Japan).  Prior to seeding on FN-coated SAMs, MC3T3-E1 cells were maintained 
in α-Modified Eagle’s Medium supplemented with 10% fetal bovine serum and 1% 
penicillin-streptomycin and subcultured every 2 days using standard techniques. 
 
Integrin Binding Analyses  
Integrin binding to FN adsorbed onto SAMs was quantified using a cross-
linking/extraction biochemical method developed by our group33,40 and modified to 




subunits was carried out to validate biochemical quantification and examine bound integrin 
localization.  For biochemical quantification, SAMs were coated with a range of FN 
surface densities for 30 minutes, then blocked in 1% hd-BSA for 30 minutes.  MC3T3-E1 
cells were seeded at 500 cells/mm2 under serum-free conditions (2 mM dextrose in DPBS) 
for either 30 or 90 minutes.  Cold sulfo-BSOCOES (1mM in DPBS) was then added for 30 
minutes.  Unreacted cross-linker was quenched for 10 minutes by the addition of 50 mM 
Tris in 2 mM dextrose-DPBS.  Uncross-linked cellular components were then extracted in 
0.1% SDS + 350 µg/ml phenylmethylsulfonyl fluoride (protease inhibitor) in DPBS.  
Cross-linked integrins were probed with integrin-specific antibodies and either quantified 
by ELISA using an alkaline phosphatase-conjugated antibody (1/1000 dilution) as 
described above or visualized by immunofluorescence staining using a fluorescence probe-
conjugated antibody (1/200 dilution) as described previously.34 
 
Cell Adhesion Assay 
Cell adhesion to SAMs was measured using a centrifugation assay to apply well-
controlled detachment forces.  SAMs were coated with a range of FN surface densities 
for 30 minutes and blocked in 1% hd-BSA or 0.1% non-fat dry milk for 30 minutes to 
prevent non-specific adhesion to the substrate.  MC3T3-E1 cells were labeled with 2 
µg/mL calcein-AM, a membrane permeable fluorescent dye, and seeded at 200 cells/mm2 
in 2 mM dextrose-DPBS into reassembled chamber slides for 30 minutes at room 
temperature.  Initial fluorescence intensity was measured to quantify the number of 
adherent cells prior to application of centrifugal force.  After filling the wells with media 




centrifuge (Beckman Allegra 6, GH 3.8 rotor) to apply a specified centrifugal force (46g).  
This detachment force was chosen because it resulted in a sigmoidal adhesion profile 
providing sufficient resolution to discriminate among FN surface densities.  After 
centrifugation, media was exchanged and fluorescence intensity was read to measure 
remaining adherent cells.  For each well, adherent cell fraction was calculated as the ratio 
of post-spin to pre-spin fluorescence readings.   
 
Curve-Fits and Statistics 
Non-linear regression was used to curve-fit experimental data to selected models 
using SigmaPlot 5.0 (SPSS, Chicago, IL), yielding R2 values of 0.90 or better.  Results 
were analyzed by one-way ANOVA using SYSTAT 8.0 (SPSS).  If treatments were 
determined to be significant, pair-wise comparisons were performed using Tukey post-
hoc test.  A 95% confidence level was considered significant.  
 
RESULTS 
Model Surfaces with Well-Defined Chemistry  
Four functional end groups X (X = CH3, OH, COOH, NH2) were chosen to 
examine a wide range of surface chemistries.  The CH3 SAM presents a non-polar 
hydrophobic surface, while the OH SAM provides a neutral hydrophilic surface.  At the 
experimental physiological pH of 7.4, the COOH SAM presents a negatively charged 
surface (COO−), while the NH2 SAM displays a positively charged surface (NH3+).  
Surface properties were verified by advancing contact angle measurements (Figure 4.1B) 




information on wettability and surface energy, and the values obtained are in agreement 
with those reported in literature.23,30,45  Variable-angle XPS was used to obtain 
information on SAM composition and assembled alkanethiol orientation.  Values 
obtained are in agreement with theoretical compositions, within the sensitivity of the 
instrument.  Comparing atomic percentages at multiple depths of analysis indicated that 
SAMs were oriented correctly, with the sulfur atom at the greatest depth from the surface 
and the functional tail groups being closest to the surface.  Taken together, these analyses 
confirmed the expected surface characteristics for each of the four SAMs. 
 
FN Adsorption onto SAMs 
FN adsorption onto SAMs was measured as a function of FN coating 
concentration using radiolabeled FN.  Figure 4.2 shows adsorption profiles exhibiting a 
linear adsorption regime at low coating concentrations and a saturation plateau at higher 
concentrations, as expected for single component adsorption.6  These results are in 
agreement with previous results on FN adsorption onto several synthetic substrates.33,46  
Results for adsorbed FN density (FNads) vs. coating concentration ([FN]) were curve-fit 
to a simple hyperbola (FNads = FNsat * [FN] / ([FN] + [FN]50)) to obtain estimates for the 
saturation density (FNsat) and the FN concentration for half-maximal adsorption ([FN]50) 
(Table 4.2).  Analysis of curve-fit parameters revealed significant differences in 
saturation density (p < 0.000012) and the concentration for half-maximal adsorption (p < 
0.013) among SAMs.  FN adsorption onto OH SAM was lower than adsorption onto the 
other functionalities, consistent with other work reporting differences in protein 




FN adsorption among NH2, COOH, and CH3 SAMs at low coating concentrations, 
adsorption saturated at higher levels for the positively charged NH2 SAM compared to 
the negatively charged COOH. 
 
SAM-dependent Changes in Adsorbed FN Conformation 
 An antibody-based assay was used to examine differences in the structure or 
conformation of FN adsorbed onto different surface chemistries.  This approach has been 
previously used by several groups to study substrate-induced changes in adsorbed 
proteins.13,20,30,33  We used monoclonal antibodies that block adhesion to the central cell-
binding domain of FN to examine the sensitivity of this functional region to adsorption 
onto different surface chemistries.  3E3 maps to the 10th type III repeat43 while HFN7.1 
maps to the flexible linker between the 9th and 10th type III repeats.44,58  For each SAM, 
antibody binding increased in a sigmoidal fashion with FN surface density, displaying a 
toe-in region at low FN surface densities, a transition region at intermediate densities, and 
a saturation regime at higher FN surface densities (Figures 4.3 and 4.4).  The antibody 
binding profile is strongly dependent on the binding affinity of the antibody for the 
adsorbed FN and left-right shifts in the binding profile reflect differences in binding 
affinity to adsorbed FN.  These changes in antibody binding affinity reflect substrate-
dependent differences in the functional presentation of FN, which includes differences in 
the adsorbed structure and orientation.  As demonstrated in Figures 4.3 and 4.4, antibody 
binding profiles exhibited significant shifts among SAMs.  The bound antibody (ABbound) 
vs. FN surface density (FNads) profiles were curve-fit to a symmetric sigmoid (ABbound = 




for half-maximal antibody binding (FNAB-50) (Tables 4.3 and 4.4).  The parameters 
ABbkgd and ABsat represent the background and saturation levels of bound antibody, 
respectively, while b corresponds to the slope of the curve at the inflection point.  
Importantly, the FNAB-50 parameter represents the inverse of the antibody binding affinity 
and is characteristic for a particular antibody-adsorbed FN pair.  For instance, a leftward 
shift in binding profile reflects enhanced ability of the antibody to bind adsorbed FN at 
lower surface densities, representing a higher binding affinity and a smaller FNAB-50.  
Analysis of FNAB-50 parameters revealed significant differences in binding affinity among 
SAMs – HFN7.1 antibody (p < 0.000023): OH > COOH = NH2 > CH3; 3E3 antibody (p 
< 8 x 10-7): OH > COOH > CH3 = NH2.  These results indicate significant differences in 
the functional presentation of the central cell-binding domain of FN upon adsorption to 
different surface chemistries. 
 
Integrin Binding to FN-coated SAMs 
We quantified integrin binding to FN adsorbed onto SAMs via a cross-linking and 
extraction biochemical method that uses a water-soluble, cell membrane-impermeable, 
homobifunctional cross-linker (sulfo-BSOCOES) to cross-link integrins to their bound 
ligands.33  This method takes advantage of the fact that many extracellular matrix 
proteins, including FN, are resistant to mild detergent extraction.  After cross-linking, the 
bulk of cell components was extracted, leaving behind the FN adsorbed on the surface 
with their bound integrins.  Control experiments with non-activated integrins have shown 
cross-linker specificity for integrins bound to their extracellular matrix ligand, without 




unbound receptors, bound integrins were quantified via ELISA using antibodies specific 
for the α5 integrin subunit.  Since the α5 subunit only dimerizes with the β1 subunit, 
measurements of α5 binding directly reflect binding of the α5β1 integrin, the classic 
fibronectin receptor.  This analysis revealed significant differences in α5-integrin binding 
to FN adsorbed onto SAMs as demonstrated by shifts in bound α5 vs. FN density profiles 
among SAMs (Figure 4.5).  To quantitatively compare the effects of surface chemistry 
on integrin binding to FN-coated SAMs, measurements of bound integrin (α5bound) as a 
function of adsorbed FN density (FNads) were curve-fit to a symmetrical sigmoid (α5bound 
= α5bkgd + α5sat / [1 + exp{-(FNads – FNα5-50)/d}]) to obtain values for the FN density 
required for half-maximal integrin binding (FNα5-50) (Table 4.5).  The parameters α5bkgd 
and α5sat correspond to background and saturation levels of bound integrin, respectively, 
while d is the slope of the curve at the inflection point.  In a manner analogous to the 
antibody binding analysis described above, FNα5-50 is inversely proportional to integrin 
binding affinity for adsorbed FN.  Analysis of FNα5-50 revealed significant differences in 
integrin binding affinity among SAMs (p < 0.0014) following the pattern OH > COOH = 
NH2 > CH3.  
Integrin binding to FN-coated SAMs was also investigated by 
immunofluorescence staining of cells plated onto equivalent FN surface densities (40 
ng/cm2) for 90 min and cross-linked and extracted as before.  In excellent agreement with 
the biochemical quantification, immunofluorescence staining for α5 integrin subunit 
demonstrated substrate-dependent differences in α5β1 integrin binding to adsorbed FN 
(Figure 4.6).  Furthermore, cell spreading and, more importantly, clustering of α5β1 




low levels of bound α5β1 integrin, cells on the other surface functionalities exhibited 
significant assembly of α5β1 integrin-containing complexes and showed differences in 
the localization and distribution of these α5β1 integrin clusters.  The COOH SAM 
displayed robust integrin clusters throughout the entire spread area of the cell, while cells 
on the OH SAM featured fewer integrin clusters at the center of the spread area but 
maintained intense receptor clustering at the cell periphery.  Interestingly, cells on the 
NH2 SAM showed localization of integrin clustering at the periphery of the cell but 
absent in the center of the spread area.  Finally, although excellent agreement was 
observed between both methods to examine integrin binding, it is important to point out 
that the biochemical method provides quantitative measures of total α5β1 integrin bound, 
while immunofluorescent staining is biased to detect clustered receptors.  Nonetheless, 
these two approaches revealed substrate-dependent differences in α5β1 integrin binding to 
adsorbed FN.   
Immunofluorescence staining also revealed SAM-dependent differences in the 
binding of αV integrin subunit to adsorbed FN (Figure 4.6), most likely reflecting 
differences in αVβ3 integrin binding.  While the CH3, OH, and NH2 SAMs exhibited little 
binding of αV above non-specific staining of remaining nuclear material, the COOH 
surface displayed punctate clusters containing αV integrin.  Of particular importance, this 
analysis revealed that FN-coated SAMs exhibited integrin specificity – the COOH 
surface supported both α5β1 and αvβ3 integrin binding, while the OH and NH2 
functionalities selectively recruited α5β1.  Biochemical quantification of bound αV 
integrin showed slight differences among SAMs but due to higher background levels (as 




analysis of integrin binding to FN-coated SAMs revealed differences in integrin binding 
affinity and specificity among surface chemistries. 
 
Cell Adhesion to FN-coated SAMs 
We used a centrifugation assay to apply controlled and reproducible forces to 
adherent cells in order to quantify MC3T3-E1 cell adhesion to SAMs as a function of FN 
density.  For a fixed centrifugal force, the fraction of adherent cells increased in a 
sigmoidal fashion with FN surface density (Figure 4.7).  Shifts in the adhesion profile 
(adherent fraction vs. FN density) reflect differences in adhesion strength.  For instance, a 
leftward shift indicates higher adhesion levels at lower FN densities, reflecting an 
increase in adhesion strength.  Considerable differences were observed in adhesion 
profiles among SAMs.  The OH SAM showed the greatest level of cell adhesion at lower 
FN densities, while the COOH and NH2 SAMs had comparable levels of adhesion at 
intermediate FN densities, and the CH3 SAM demonstrated equivalent levels of adhesion 
only at the highest FN surface density.  Profiles for adherent fraction (f) as a function of 
FN density (FNads) were curve-fit to a symmetric sigmoid (f = fsat / [1 + exp{-(FNads – 
FNADH-50)/g}]) to obtain estimates for the FN density for half-maximal adhesion (FNADH-
50) (Table 4.6).  The parameters fsat and g represent the maximum adhesive fraction and 
the slope of the curve at the inflection point, respectively.  The parameter FNADH-50 
represents the surface density of FN required for 50% maximal adhesion and was used as 
a measure of adhesion strength.  This analysis revealed significant differences in 
adhesion strength among FN-coated SAMs (p < 2 x 10-8) following the trend: OH > 




binding profile.  Blocking experiments with function-perturbing antibodies demonstrated 
that cell adhesion to adsorbed FN was mediated by α5β1 integrin as antibodies against the 




 A fundamental understanding of substrate-directed control of cell function is 
critical to the rational design of surfaces relevant to biomaterials, tissue engineering 
scaffolds, and in vitro culture supports for biotechnological applications.  In the present 
work, using model substrates with well-controlled surface properties, we demonstrate that 
surface chemistry modulates the functional presentation of adsorbed FN to direct integrin 
binding and specificity, thereby controlling cell adhesion.  Our results reveal quantitative 
differences in the functional presentation of the major integrin-binding domain of FN, 
α5β1 integrin binding, and cell adhesion among FN-coated SAMs (Table 4.7), as well as 
differences in the composition and localization of integrins to focal adhesion complexes.  
These surface chemistry-dependent changes in integrin binding and adhesion may 
provide a versatile strategy to control downstream cellular activities such as proliferation 
and expression of tissue-specific phenotypes, for various biomedical and biotechnological 
applications. 
Antibody-based measurements using monoclonal antibodies revealed differences 
in antibody affinity for FN adsorbed onto different chemistries.  These differences in 
antibody binding affinity reflect alterations in the functional presentation of the particular 




others13,20,49 and, more recently, McClary and colleagues who demonstrated changes in 
adsorbed FN conformation between CH3 and COOH SAMs.30  In the present work, the 
central cell-binding domain of FN, spanning the 9th and 10th type III repeats of the 
molecule, was particularly sensitive to adsorption onto different chemistries as 
determined by changes in the binding affinities of the HFN7.1 and 3E3 antibodies.  
Structural alterations in this region of FN may have significant consequences for 
downstream cellular activities because this region contains critical binding domains for 
several integrins, including the RGD recognition site.  Notably, binding of α5β1 integrin 
to fibronectin requires both the PHSRN sequence in the 9th type III repeat and the RGD 
motif in the 10th type III repeat of the molecule.50  Each domain independently 
contributes little to binding, but in combination, they synergistically bind to the integrin 
to produce significant increases in adhesion strength.51,52  Furthermore, the structural 
orientation of these binding domains is crucial to the synergistic effects as increases in 
the relative distance between the PHSRN and RGD sites completely abrogate α5β1 
binding, cell spreading, and integrin-mediated signaling.53  Adsorption-induced changes 
in the structural orientation of these two binding domains may explain the observed 
substrate-dependent differences in integrin binding and cell adhesion.  
These substrate-dependent differences in functional presentation among SAMs 
motivated us to investigate whether a minimum “active” or functional FN density exists 
independently of surface chemistry.  Using antibody binding as a metric of functional 
presentation, cell adhesion was plotted as a function of HFN7.1 binding (Figure 4.8).  
When normalized by antibody binding, the adhesion profiles for all SAMs collapse into a 




maximum cell adhesion.  This concept of a minimum active FN density is consistent with 
the findings of Massia and Hubbell, who reported a minimum ligand density of tethered 
RGD peptide required for cell spreading and focal adhesion assembly.61  Notably, 
HFN7.1 antibody proved to be an effective probe for the presentation of integrin binding 
sites in FN adsorbed onto different supports. 
A significant contribution of this work is the rigorous analysis of integrin binding 
to FN adsorbed onto different surface chemistries.  Using biochemical and 
immunostaining methods, we demonstrate significant substrate-dependent differences in 
integrin binding, localization, and specificity for adsorbed FN, providing new 
information on the mechanisms controlling cell-substrate interactions.  The substantial 
differences in integrin α5β1 binding among FN-coated SAMs correlate strongly with, and 
most likely result from, the observed substrate-dependent differences in the structure of 
the central cell-binding domain of FN.  The differences in integrin binding among SAMs 
control subsequent differences in cell adhesion as demonstrated by blocking with 
function-perturbing antibodies.  To further investigate this relationship, adhesion strength 
(FNADH-50) for each SAM was plotted vs. the FN density required for half-maximal 
integrin binding (FNα5-50) (Figure 4.9).  While a general correlation between FNα5-50 and 
FNADH-50 exists, it is not necessarily linear, supporting contributions to cell adhesion 
strength from other factors including cell spreading, integrin clustering, and integrin-FN 
specific bond strength.54,46 
The differences in integrin binding, specificity, and localization among varying 
surface chemistries are particularly important to the understanding of cell-substrate 




to modulating short-term adhesive responses such as attachment and spreading, 
differences in integrin binding may differentially regulate integrin-mediated signaling 
and high order cellular activities, including proliferation and tissue-specific gene 
expression.  For instance, we have previously shown that differential integrin binding 
between α5β1 and αVβ3 triggers intracellular signals that control switching between 
proliferation and differentiation.33  Differences in integrin clustering may also regulate 
the composition of structural and signaling proteins localizing to focal adhesion 
complexes, modulating downstream gene and protein activities.  Moreover, integrin 
distribution along the cell-substrate interface is critical in controlling the distribution of 
forces throughout the cell and influences overall adhesion strength.54 
Our results indicate graded increases in accessibility of binding domains in FN, 
integrin binding, and cell adhesion as a function of underlying surface chemistry 
following the trend OH > COOH = NH2 > CH3.   These findings are consistent with 
previous reports showing enhanced cell adhesion and spreading on COOH and OH SAMs 
compared to CH3 SAMs.30,55,32  Scotchford et al. reported higher levels of cell attachment 
and clustered α5β1 and αVβ3 integrins (COOH > CH3).55  In constrast to the present work, 
Scotchford and colleagues reported higher levels of attachment on COOH compared to 
OH SAMs.  However, this study did not control for the density of adsorbed FN, which 
for the same coating concentration is greater for the COOH than the OH monolayer 
(Figure 4.2).  Tidwell et al. also reported poor adhesion and cell growth on OH SAMs 
compared to CH3 and COOH SAMs, but these substrates were incubated in serum-




Adsorption of FN onto the non-polar CH3 SAM essentially destroyed α5β1 
integrin binding and cell adhesion for most FN surface densities, while the OH 
functionality resulted in the highest levels of integrin affinity and cell adhesion.  These 
results are consistent with previous studies suggesting that hydrophobic surfaces strongly 
denature adsorbed proteins.13,20,33,49,23,59,60  For instance,  Wertz and Santore demonstrated 
higher rates of interfacial relaxation or partial unfolding for proteins adsorbing to CH3 
surfaces compared to OH monolayers.  Lower rates of protein unfolding on the OH 
monolayer compared to the CH3 surface are consistent with our observations of enhanced 
functional presentation and cell activities. Finally, the present work provides an 
experimental framework to analyze adhesive mechanisms controlling cell-surface 
interactions and our findings contribute to the general understanding of cell-protein-
surface interactions.  However, detailed structure-function analyses, including molecular 
modeling of the adsorption process57, are required to provide a more complete 
understanding of mechanisms directing cellular responses to synthetic surfaces. 
In conclusion, using model substrates with well-controlled surface properties, we 
demonstrate that surface chemistry alters the functional presentation of the major 
integrin-binding domain of adsorbed FN and modulates integrin binding, localization, 
and specificity.  These differences in integrin receptor binding control subsequent cell 
adhesion activities, providing new insights on mechanisms regulating cell-substrate 
interactions.  Furthermore, substrate-directed control of adsorbed protein activity to 
manipulate integrin binding represents a versatile approach to elicit specific cellular 
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 Angle C1s (%) O1s (%) N1s (%) S2p (%) 
30° 97.6 - - 2.4 
75° 96.0 - - 4.0 CH3
theoretical 92.3 - - 7.7 
30° 83.2 13.3 - 3.5 
75° 85.2 10.6 - 4.1 OH 
theoretical 84.6 7.7 - 7.7 
30° 79.4 18.9 - 1.8 
75° 80.1 17.8 - 2.2 COOH 
theoretical 79.0 14.0 - 7.0 
30° 86.6 - 11.9 1.5 
75° 90.1 - 6.3 3.8 NH2





Table 4.1. Variable-angle XPS measurements of self-assembled monolayers of
alkanethiols on gold.  Angle is measured from the plane of the surface.  Excellent





 Adsorption Parameters Tukey Pair-Wise Comparison for FNsat
 FNsat(ng/cm2) 
[FN]50
(µg/mL) OH COOH NH2
CH3 360 ± 76 14 ± 4.6 p < 0.00007 n.s. n.s. 
OH 110 ± 83 7.2 ± 2.4 - p < 0.004 p < 0.00002 
COOH 280 ± 43 12 ± 1.5 - - p < 0.032 




Table 4.2. Hyperbolic curve-fit parameters for FN adsorption showing differences among
SAMs (n.s.-not significant).  Data presented as mean ± standard deviation (three separate




  Tukey Pair-Wise Comparison  
 FNAB-50 (ng/cm2) OH COOH NH2
CH3 210 ± 12 p < 0.000028 p < 0.023 n.s. 
OH 32 ± 6.5 - p < 0.00076 p < 0.000072 
COOH 150 ± 29 - - n.s. 
NH2 180 ± 20 - - - 
 
 
Table 4.3. HFN7.1 monoclonal antibody FNAB-50 values for FN-coated SAMs obtained 
from sigmoidal curve-fits, demonstrating significant differences in antibody binding 
affinity among SAMs (n.s.-not significant).  FNAB-50 values are mean ± standard 




  Tukey Pair-Wise Comparison  
 FNAB-50  (ng/cm2) OH COOH NH2
CH3 160 ± 48 p < 0.0000063 p < 0.028 n.s. 
OH 24 ± 13 - p < 0.00016 p < 0.000011 
COOH 110 ± 44 - - n.s. 




Table 4.4. 3E3 monoclonal antibody FNAB-50 values for FN-coated SAMs obtained from 
sigmoidal curve-fits demonstrating significant differences in antibody binding affinity 
among SAMs (n.s.-not significant).  FNAB-50 values are mean ± standard deviation (three 
separate runs, in duplicate). 
 
 
  Tukey Pair-Wise Comparison  
 FNα5-50  
(ng/cm2) OH COOH NH2
CH3 150 ± 48 p < 0.00079 p < 0.043 p < 0.048 
OH 15 ± 8.0 - p < 0.047 p < 0.042 
COOH 84 ± 12 - - n.s. 




Table 4.5. FNα5-50 values for MC3T3-E1 cells on FN-coated SAMs obtained from 
sigmoidal curve-fits demonstrating significant differences in α5β1 integrin binding among 
SAMs (n.s.-not significant).  FNα5-50 values are mean ± standard deviation (three separate 
runs, in duplicate). 
 
 
  Tukey Pair-Wise Comparison  
 FNADH-50  (ng/cm2) OH COOH NH2
CH3 240 ± 43 p < 0.0000084 p < 0. 0000084 p < 0. 0000084 
OH 19 ± 8.1  - p < 0.0027 p < 0.000093 
COOH 56 ± 9.5 - - p < 0.015 




Table 4.6. FNADH-50 values for MC3T3-E1 adhesion to FN-coated SAMs demonstrating 
differences in cell adhesion among SAMs.  Values are mean ± standard deviation (three 




 FN Conformation / α5 Binding / Adhesion 
 OH COOH NH2
CH3 + / + / + + / + / + −/ + / + 
OH - + / + / + + / + / + 
COOH - - − / − / + 
 
Table 4.7.  Summary of FN conformation/integrin binding/cell adhesion results showing 

















































CH3 107 ± 1º 
OH 25 ± 3º 
COOH 28 ± 1º 
NH2 43 ± 3º 
Figure 4.1. SAM structure and characterization by contact angle.  A. Functionalized 
alkanethiol SAMs on Au presenting tail group X.  B. Shown are drop profiles and contact 
angle measurements (mean ± standard deviation) using 5 µL water-drops on SAMs at 
ambient conditions.  3-4 drops were analyzed with contact angles measured on both sides 




































Fn Coating Concentration (µg/mL)
Figure 4.2.  FN adsorption on SAMs as a function of coating concentration showing 
differences among SAMs.  Data is plotted as mean ±  standard deviation (three separate 
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Figure 4.3. Bound HFN7.1 monoclonal antibody (relative fluorescence intensity), as a
function of FN surface density demonstrating substrate-dependent differences in antibody
binding affinity among SAMs.   Shown are representative data (mean ± standard
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Figure 4.4. Bound 3E3 monoclonal antibody (relative fluorescence intensity) as a 
function of FN surface density demonstrating substrate-dependent changes in antibody 
binding affinity among SAMs.  Shown are representative data (mean ± standard 































Figure 4.5. α5β1 integrin binding as a function of FN surface density demonstrating 
differences in integrin binding of MC3T3-E1 cells seeded on FN-coated SAMs.  Shown 



























Figure 4.6. Immunofluorescence staining for α5 and αV integrin subunits on MC3T3-E1 
cells (one cell per frame) seeded serum-free for 90 min on FN (40 ng/cm2) demonstrating 
differences in clustering and localization among surface chemistries.  Focal adhesion 
complexes display characteristic discrete spear-like structures.  Arrows indicate residual 
nuclear background staining. 
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NH2Figure 4.7. Adherent fraction of MC3T3-E1 cells seeded on FN-coated SAMs, as a 
function of FN surface density demonstrating differences in cell adhesion among SAMs. 
Shown is representative data (mean ± standard deviation) and sigmoidal curve-fits for 
one experimental run. 82
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Figure 4.8.  Adherent fraction of MC3T3-E1 cells seeded on FN-coated SAMs, as a
function of functional FN surface density, as measured by HFN7.1 antibody binding (in
RFI), demonstrating a minimum “active” FN surface density to produce maximum cell
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 Figure 4.9. Relationship between FNα5-50 and FNADH-50 showing positive correlation
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              CHAPTER 5: SURFACE CHEMISTRY MODULATES FOCAL ADHESION COMPOSITION AND SIGNALING THROUGH CHANGES IN INTEGRIN BINDING 
 
SURFACE CHEMISTRY MODULATES FOCAL ADHESION COMPOSITION 
AND SIGNALING THROUGH CHANGES IN INTEGRIN BINDING*
 
SUMMARY 
Biomaterial surface properties influence protein adsorption and elicit diverse cellular 
responses in biomedical and biotechnological applications.  However, the molecular 
mechanisms directing cellular activities remain poorly understood.  Using a model system 
with well-defined chemistries (CH3, OH, COOH, NH2) and a fixed density of the single 
adhesive ligand fibronectin, we investigated the effects of surface chemistry on focal 
adhesion assembly and signaling.  Surface chemistry strongly modulated integrin binding 
and specificity – α5β1 integrin binding affinity followed the pattern OH > NH2 = COOH > 
CH3, while integrin αVβ3 displayed the relationship COOH > NH2 >> OH = CH3.   
Immunostaining and biochemical analyses revealed that surface chemistry modulates the 
structure and molecular composition of cell-matrix adhesions as well as FAK signaling.  
The neutral hydrophilic OH functionality supported the highest levels of recruitment of 
talin, α-actinin, paxillin, and tyrosine-phosphorylated proteins to adhesive structures.  The 
positively charged NH2 and negatively charged COOH surfaces exhibited intermediate 
levels of recruitment of focal adhesion components, while the hydrophobic CH3 substrate 
displayed the lowest levels.  These patterns in focal adhesion assembly correlated well with 
integrin α5β1 binding.  Phosphorylation of specific tyrosine residues in FAK also showed 
differential sensitivity to surface chemistry.  These differences in focal adhesion assembly 
 * Keselowsky, B.G., Collard, D.M. and García, A.J. Biomaterials. (in press). 
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and signaling provide a potential mechanism for the diverse cellular responses elicited by 
different material properties.   
 
INTRODUCTION 
Cell adhesion to synthetic surfaces is crucial to many biomedical and 
biotechnological applications.1-6  In addition to anchoring cells, adhesive interactions 
activate various intracellular signaling pathways that direct cell viability, proliferation, 
and differentiation.7,8  In many instances, cell adhesion to biomaterial surfaces is 
mediated by a layer of adsorbed proteins, such as immunoglobulins, vitronectin, 
fibrinogen and fibronectin (FN).9,10  Numerous studies have shown that the type, quantity 
and activity of adsorbed proteins are influenced by the underlying substrate properties, 
including chemistry and hydrophobicity.9,11-16  These substrate-dependent differences in 
protein adsorption have profound effects on cellular activities, including integrin receptor 
binding and subsequent cell adhesive events.17-23  Several studies have demonstrated 
diverse cellular responses to substrates with different surface chemistries.  For instance, 
Allen et al. showed differential gene expression for several cell types on surfaces of 
varying hydrophobicity.24  Similarly, Brodbeck and colleagues demonstrated increased in 
vivo apoptosis and reduced foreign body giant cell formation on hydrophilic and anionic 
surfaces compared to hydrophobic and cationic substrates.25  While these studies 
highlight the importance of biomaterial surface properties in modulating cellular 
behaviors, the underlying mechanisms responsible for generating dissimilar cell 




Using model substrates with well-controlled surface properties, we recently 
reported that surface chemistry alters the adsorption kinetics and structure of adsorbed 
FN.26   Furthermore, we demonstrated that surface chemistry modifies the functional 
presentation of the major integrin binding domain of FN, alters integrin binding, and 
potentiates cell adhesion strength.23  In the present work, we analyzed the effects of 
surface chemistry on focal adhesion assembly and signaling.  Focal adhesions are 
specialized adhesive complexes containing structural and signaling molecules that 
regulate cell migration, survival, cell cycle progression, and differentiation.27,28  We 
demonstrate that surface chemistry modulates focal adhesion composition and signaling.  
These findings provide a potential mechanism for the diverse cellular responses to 
biomaterial surfaces and offer design criteria for the engineering of surfaces that elicit 
specific cellular responses.  
 
MATERIALS AND METHODS  
Cells and reagents 
Human plasma FN and other tissue culture reagents were obtained from 
Invitrogen (Carlsbad, CA).  Fetal bovine serum was purchased from Hyclone (Logan, 
UT).  Bovine serum albumin, anti-talin (clone 8D4) and anti-α-actinin (BM-75.2) 
monoclonal antibodies, alkaline phosphatase-conjugated anti-biotin antibody (BN-34), 
and all other chemical reagents were obtained from Sigma Chemical (St. Louis, MO).  
Bis(2-(sulfo-succinimidooxycarbonyloxy)ethyl)sulfone (sulfo-BSOCOES) cross-linker 
was purchased from Pierce Chemical (Rockford, IL).  Anti-paxillin (Z035) and anti-




Francisco, CA).  Anti-vinculin (V284) and anti-FAK antibodies were purchased from 
Upstate (Lake Placid, NY).  Antibodies against phosphotyrosine FAK, pFAK Tyr-576, 
pFAK Tyr-397 and pFAK Tyr-861, were obtained from Biosource International 
(Camarillo, CA).  HFN7.1 monoclonal antibody directed against human plasma FN was 
obtained from the Developmental Studies Hybridoma Bank (Iowa City, IA).  Rabbit 
antibodies against mouse integrin subunits were purchased from Chemicon (Temecula, 
CA).  Alexa Fluor 488-conjugated anti-rabbit and anti-mouse IgG antibodies were 
acquired from Molecular Probes (Eugene, OR), while biotinylated anti-rabbit IgG and 
alkaline phosphatase-conjugated anti-rabbit IgG antibodies were purchased from Jackson 
ImmunoResearch (West Grove, PA).   
MC3T3-E1 cells, an immature osteoblast-like cell line, were obtained from the 
RIKEN Cell Bank (Tokyo, Japan).  Prior to seeding on FN-coated substrates, MC3T3-E1 
cells were maintained in α-Modified Eagle’s Medium supplemented with 10% fetal 
bovine serum and 1% penicillin-streptomycin and passaged every 2 days using standard 
techniques. 
 
Model surfaces with well-defined chemistries 
 Self-assembled monolayers (SAMs) of alkanethiols on gold were used as model 
substrates with well-defined chemistries.29-31  Alkanethiols 1-dodecanethiol (HS-(CH2)11-
CH3), 11-mercapto-1-undecanol (HS-(CH2)11-OH) and 11-mercaptoundecanoic acid (HS-
(CH2)10- COOH) were purchased from Aldrich Chemical (Milwaukee, WI) and used as 
received.  The amine-terminated alkanethiol, 12-amino-1-mercaptododecane (SH-




respective alkanethiols are referred to hereafter as CH3, OH, COOH and NH2 SAMs.  
Gold-coated substrates were prepared by sequential deposition of optically transparent 
films of titanium (10 nm) and gold (20 nm) onto clean glass coverslips or tissue culture 
dishes via electron beam evaporation (Thermionics Laboratories, Hayward, CA) at 1-2 x 
10-6 torr with 2 Å/s deposition rate.  Freshly prepared gold surfaces were immersed in 
alkanethiol solutions (1.0 mM in absolute ethanol), and SAMs were allowed to assemble 
for 12 hr.  Surfaces were characterized by contact angle and X-ray photoelectron 
spectroscopy (XPS).23,26  XPS analyses revealed surface compositions within 5% of the 
theoretical values.  Prior to FN coating, SAMs were rinsed in ethanol, dried with N2, and 
allowed to equilibrate in Dulbecco’s phosphate buffered saline (DPBS: 137 mM NaCl, 
2.7 mM KCl, 4.3 mM Na2HPO4⋅7H2O, 1.5 mM KH2PO4, 0.9 mM CaCl2⋅2H2O, 1 mM 
MgCl2⋅6H2O, pH 7.4) for 15 min.  SAMs were coated for 30 min with different FN 
concentrations and blocked for 30 min in 1% heat-denatured serum albumin.  Adsorbed 
FN densities were previously quantified with 125I-labeled FN.23 
 
Cell adhesion assay 
Cell adhesion was quantified using a centrifugation assay.32  This assay applies a 
single detachment force and allows estimation of cell adhesion strength.  Calcein-labeled 
cells were seeded on FN-coated SAMs for 30 min and subjected to a 46g detachment 
force using a Beckman GS-6R centrifuge with a swinging bucket rotor.  Adherent cell 
fraction (post-spin to pre-spin readings) vs. FN density was curve-fit to a sigmoid to 
obtain estimates of the FN surface density required for 50% detachment.  This parameter 





Integrin binding and focal adhesion assembly assays 
Integrin binding to FN-coated SAMs was quantified using a cross-
linking/extraction biochemical method that selectively isolates bound integrins.33,23  
MC3T3-E1 cells were seeded at 500 cells/mm2 under serum-free conditions for 30 min.  
Ligated integrins were cross-linked with sulfo-BSOCOES (1mM) and uncross-linked 
cellular components were extracted in 0.1% SDS + 350 µg/ml phenylmethanesulfonyl 
fluoride (PMSF).  Cross-linked integrins were quantified by ELISA.   
For immunostaining of focal adhesions, cells were seeded on FN-coated (40 
ng/cm2) SAMs at 3,000 cells/cm2 for 1 hr under serum-free conditions.  Cells were then 
permeabilized for 5 min in 0.5% Triton X-100 in 50 mM Tris (pH 6.8), 50 mM NaCl, 
150 mM sucrose, 3 mM MgCl2 supplemented with 10 µg/mL PMSF, leupeptin, aprotinin, 
and 10mM Na3VO4, and fixed in cold 3.6% formaldehyde for 5 min.  After blocking with 
5% serum, cultures were incubated with primary and secondary antibodies.23 
Focal adhesion proteins localized to adhesive complexes were isolated and 
quantified by a modified wet-cleaving technique.34,35  Briefly, cells were seeded at 400 
cells/mm2 on FN-coated (40 ng/cm2) SAMs for 1 hr under serum-free conditions. Cells 
were washed with DPBS, and a nitrocellulose sheet (PROTRAN BA85, Schleicher & 
Schuell) was overlaid on the cells for 1 min.  Cells were then cleaved by rapidly lifting 
the nitrocellulose sheet, and cleaved surfaces were rinsed in DPBS and scraped in 
Laemmli sample buffer.  Recovered proteins were analyzed by Western blotting.36,33  
DNA was solubilized from corresponding nitrocellulose sheets and quantified by SYBR 




plates were cleaved and examined by immunofluorescence staining to corroborate 
Western blotting analyses. 
   
FAK phosphorylation 
Cells were gently agitated in serum-free suspension for 45 min to reduce 
background signaling, and seeded at 400 cells/mm2 for 1 hr on FN-coated SAMs.  After 
rinsing in DPBS, cells were lysed in RIPA buffer (1% Triton X-100, 1% deoxycholate, 
0.1% SDS, 150 mM Tris (pH 7.2), 10 µg/mL PMSF, leupeptin, aprotinin, and 10 mM 
Na3VO4).  Total protein was quantified using micro-BCA (Pierce, IL), and equal amounts 
of total protein were analyzed by Western blotting and image analysis.  Phosphorylated 
FAK levels were normalized to total FAK. 
 
Statistical analyses 
Results were analyzed by mixed-model ANOVA using SYSTAT 8.0 (SPSS Inc., 
IL).  For treatments that were determined to be significant, pair-wise comparisons were 




Surface chemistry modulates integrin binding and cell adhesion 
Ordered and well-packed SAMs of ω-functionalized alkanethiols on gold were used 
to present four chemistries: (i) CH3 (hydrophobic), (ii) OH (neutral hydrophilic), (iii) 




to cell seeding, surfaces were coated with a specified FN density and blocked with non-
adhesive albumin to prevent adsorption of additional proteins which may influence cell 
behaviors.  Surfaces densities were characterized following coating and washing steps and 
reflect tightly adsorbed proteins.  This model provides a well-defined system with 
controlled densities of a single adhesive ligand and allows rigorous analysis of the effects 
of surface chemistry on cell adhesion.  Using this system, we recently demonstrated that 
surface chemistry alters the structure and functional presentation of the major integrin 
binding domain in FN.23,26  This system, however, does not prevent long-term, cell-
mediated extracellular matrix reorganization. 
Surface chemistry strongly modulated integrin binding and specificity to adsorbed 
FN (Fig. 5.1).  Binding of α5β1 integrin exhibited surface chemistry-dependent 
differences following the pattern in binding affinity OH > NH2 = COOH > CH3.  Integrin 
αVβ3 displayed high affinity to COOH SAM, intermediate values to the NH2 surface, and 
negligible binding to OH and CH3 SAMs.  A fixed FN density (40 ng/cm2) was selected 
to provide for equivalent ligand densities among surfaces for further analyses.  This value 
represents the saturation density for the OH SAM and is the lowest saturation density of 
all SAMs examined.23  For this FN density, the OH and NH2 surfaces displayed high 
levels of bound α5β1 integrin, while the COOH SAM supported high binding of both 
α5β1 and αVβ3, and the CH3 surface poorly bound both integrins.  Cell adhesion strength 
to adsorbed FN also displayed SAM-dependent differences (Fig. 5.2), correlating well 
with integrin binding.  Function-perturbing antibodies directed against human FN or 




adsorbed FN, not proteins adsorbed from solution or deposited by the cells, provided the 
primary adhesion mechanism in this model.   
 
Surface chemistry alters focal adhesion assembly 
Since integrin binding and clustering control focal adhesion assembly, we 
investigated the localization of specific structural (vinculin, talin, α-actinin) and signaling 
(paxillin, tyrosine-phosphorylated proteins) components to adhesion plaques on FN-coated 
SAMs.  Analysis of focal adhesion assembly by complementary biochemical and 
immunofluorescence staining approaches revealed SAM-dependent modulation of the 
molecular composition and structure of cell-FN adhesions (Table 5.1, Fig. 5.3 and Fig. 
5.4).  Vinculin localized to large (> 3 µm long), highly oriented complexes on the NH2 and 
COOH SAMs, while forming a high number of smaller, more punctate clusters on the OH 
functionality, and fewer and poorly defined structures on the CH3 surface (Fig. 5.3). In 
excellent agreement with immunofluorescence staining observations, wet-
cleaving/biochemical quantification of assembled focal adhesions displayed significant 
differences among surface chemistries (NH2 = COOH > OH > CH3, p < 0.0001, Fig. 5.3).  
In contrast to vinculin, talin clustered into robust adhesive structures in the cell periphery 
on the OH and COOH SAMs, but displayed less and smaller clusters on the NH2 surface, 
and even fewer and less mature complexes on the CH3 substrate  (Fig. 5.4).  These 
observations were confirmed biochemically (OH > COOH > NH2 = CH3, p < 0.0002, Fig. 
5.4).  Similar to talin, α-actinin localized to adhesive plaques following the pattern OH = 
COOH > NH2 > CH3 (Table 5.1).  Paxillin and tyrosine-phosphorylated proteins, 




focal adhesions, showing high levels on the OH functionality, intermediate amounts on 
COOH and NH2 surfaces, and lowest levels on the CH3 substrate (Table 5.1).  These 
results demonstrate surface chemistry-dependent differences in the composition and 
organization of focal adhesions.  
 
Surface chemistry modulates site-specific FAK phosphorylation 
 Focal adhesion kinase (FAK) localizes to focal adhesions to activate multiple 
signaling pathways that regulate cell migration, survival, proliferation, and 
differentiation.38-42  Because of the multi-functional activities of FAK, we examined the 
effects of surface chemistry on the phosphorylation of three important tyrosine residues 
using site-specific antibodies.  Phosphorylation of tyrosine-576, located in the FAK 
catalytic loop and essential for maximal kinase activity, was reduced on the CH3 substrate 
compared to the other surface chemistries (p < 0.05, Fig. 5.5A).  More importantly, 
tyrosine-397 (autophosphorylation site and SH2-binding site) and tyrosine-861 (SH2-
binding site) exhibited differential phosphorylation following the pattern NH2 > OH = 
COOH > CH3 (p < 0.05, Fig. 5.5B, 5.5C).  These results demonstrate differential 
phosphorylation of specific sites in FAK as a function of underlying surface chemistry. 
   
 
DISCUSSION 
 Biomaterial surface properties play critical roles in controlling cellular behaviors 
in host responses to implanted devices, tissue engineering scaffolds and artificial organs, 




that diverse cellular responses to synthetic surfaces arise from differences in protein 
adsorption, the molecular mechanisms directing cellular activities are not well 
understood.  Because focal adhesions function in mechanical and biochemical capacities, 
these specialized structures represent putative transducers of biomaterial properties.  In 
the present work, we used a model experimental system consisting of well-defined 
surface chemistries and a fixed density of a single adhesive ligand to analyze focal 
adhesion assembly as a function of surface chemistry.  We demonstrate that surface 
chemistry, through modulation of integrin binding, regulates focal adhesion assembly, 
composition and signaling.  This is a significant finding in the context of biomaterials 
because it provides a putative mechanism for signal transduction of biomaterial 
properties to cellular activities (e.g., adhesion and spreading, proliferation, 
differentiation) and demonstrates that differences in integrin binding differentially 
regulate specific intracellular signaling pathways.  To our knowledge, this is the first 
report of surface chemistry-dependent, integrin-mediated differences on focal adhesion 
composition and signaling.  The differences in focal adhesion assembly most likely result 
from surface chemistry-dependent differences in the functional presentation of adsorbed 
FN.23  Using monoclonal antibodies as structural probes, we demonstrated that, upon 
adsorption onto these surfaces, FN undergoes significant structural changes.23  The major 
integrin-binding RGD domain in FN was particularly sensitive to the underlying 
chemistry and presentation of this motif (as determined by antibody binding) followed 
the pattern OH > NH2 = COOH > CH3.  These changes in FN structure, in turn, 
modulated integrin binding.  These surface chemistry-dependent differences in integrin 




and signaling.  Indeed, blocking antibodies against FN or integrin subunits completely 
abolish adhesive interactions on these substrates.  Finally, it is important to note that the 
present analysis was performed on substrates with a well-defined pre-adsorbed protein 
layer to isolate the effects of surface chemistry from other factors influencing cell 
adhesion, such as differences in protein adsorption (e.g., multiple proteins, adsorbed 
density) and matrix deposition.  These other mechanisms may influence cellular 
behaviors in other experimental systems, including the case of uncoated substrates 
exposed to serum- or plasma-containing solutions. 
 Analysis of focal adhesion assembly by two independent methods revealed that 
surface chemistry modulates the structure and molecular composition of cell-matrix 
adhesions as well as FAK signaling.  In general, the neutral hydrophilic OH functionality 
supported the highest levels of recruitment to adhesive structures for talin, α-actinin, 
paxillin, and tyrosine-phosphorylated proteins.  The NH2 and COOH moieties, which 
present positively and negatively charged surfaces, respectively, exhibited intermediate 
levels of recruitment of focal adhesion components.  The hydrophobic CH3 substrate 
displayed the lowest levels of focal adhesion components.  These patterns in focal 
adhesion assembly correlate well with integrin α5β1 binding.  The trends in integrin 
binding and focal adhesion assembly are in excellent agreement with differences in cell 
adhesion strength, consistent with the anchoring functions of these structural 
components.36,33,45-48  On the other hand, vinculin recruitment exhibited higher levels on 
the charged surfaces compared to the OH SAM and did not follow the same relationship 




the tremendous complexity and inter-relationships involved in focal adhesion assembly 
and regulation.49   
Phosphorylation of FAK also showed differential sensitivity to surface chemistry.  
Phosphorylation of tyrosine-576 in the catalytic loop of FAK exhibited a binary response 
with negligible activation on the CH3 SAM and high levels on all other surfaces.  
Notably, both tyrosine-397, the autophosphorylation site in FAK and a binding site for 
src and PI-3 kinase,50,51 and tyrosine-861 exhibited highest phosphorylation on the NH2 
surface, intermediate levels on the OH and COOH functionalities, and minimal activation 
on the CH3 SAM.  Because of the important roles of these SH2-binding sites on the 
activation of signaling pathways,52 these findings suggest a mechanism for differential 
activation of signaling cascades as a function of surface chemistry. 
 We propose a model in which surface chemistry-dependent differences in integrin 
binding, both in terms of bound numbers as well as integrin specificity, differentially 
regulate focal adhesion assembly and signaling which, in turn, modulate cellular 
functions (e.g., cell adhesion strength, matrix mineralization).  This model is consistent 
with recent observations detailing integrin-specific differences in focal adhesion 
assembly and signaling.17,57-59  The present findings, however, differ from these previous 
reports in the mechanisms giving rise to differences in integrin binding and focal 
adhesion composition.  In the present study, surface chemistry-dependent differences in 
focal adhesion assembly and signaling provide a mechanism for the differential cellular 
responses elicited by different material properties.  These results contribute to the 
development of design principles for the engineering of surfaces that direct cell adhesion 
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Table 5.1: Surface chemistry differentially alters recruitment and organization of 
structural and signaling components to focal adhesions.  MC3T3-E1 cells were seeded 
serum-free for 1 hr on SAMs coated with equivalent FN surface densities (40 ng/cm2), 
fixed and immunostained.  Scoring of relative immunostaining intensity for focal 














































Figure 5.1: Surface chemistry modulates integrin binding affinity.  MC3T3-E1 cells were 
seeded serum-free for 1 hr on FN-coated SAMs.  Plotted are effective α5 and αV integrin 
binding affinities to adsorbed FN as quantified via cross-linking and extraction.  αV
binding to CH3 and OH FN-coated SAMs was negligible (neg).  Pair-wise comparison 
showed significant differences between surface chemistries (* vs. CH3; Ψ vs. COOH; Ω 




































CH3 OH COOH NH2
Figure 5.2: Surface chemistry modulates cell adhesion strength.  MC3T3-E1 cells were 
seeded serum-free for 1 hr on FN-coated SAMs.  Shown is effective cell adhesion 
strength to FN-coated SAMs.  Pair-wise comparison showed significant differences 
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Figure 5.4: Surface chemistry differentially alters recruitment and organization of focal 
adhesion component, talin.  MC3T3-E1 cells were seeded serum-free for 1 hr on SAMs 
coated with equivalent FN surface densities (40 ng/cm2).  Wet-cleaving/biochemical and 
immunolabeling analysis of talin recruitment to focal adhesions demonstrating 







































































Figure 5.5: Surface chemistry modulates site-specific phosphorylation of FAK.  Cells 
were seeded on SAMs coated with 40 ng/cm2 FN, lysed, and analyzed by Western 
blotting using phosphotyrosine-specific antibodies. (A) Representative Western blot for 
phophorylated tyrosine residues on FAK.  (B) Quantification of Western blots (n = 6). 
Pair-wise comparison showed significant differences between surface chemistries (* vs. 
CH3, p < 0.05; † vs. OH, p < 0.05; Ψ vs. COOH, p < 0.05). 
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                        CHAPTER 6: SURFACE CHEMISTRY DIRECTS OSTEOBLASTIC DIFFERENTIATION 
 
SURFACE CHEMISTRY DIRECTS OSTEOBLASTIC DIFFERENTIATION 
 
SUMMARY 
 Cell adhesion to proteins adsorbed onto synthetic surfaces anchors cells and 
triggers signals that direct cell function.  Using self-assembled monolayers (SAMs) of 
alkanethiols on gold presenting terminal CH3, OH, COOH and NH2 functionalities, we 
have shown that surface chemistry-dependent differences in FN adsorption induce 
differences in integrin binding, focal adhesion assembly and signaling, and cell adhesion 
strength.  In the present work, we extend this mechanistic study by examining the effects 
of surface chemistry on osteoblast cell responses.  While cell proliferation and alkaline 
phosphatase activity were relatively insensitive to underlying surface chemistry, 
osteoblast-specific gene expression and matrix mineralization exhibited significant 
differences among surface functionalities.  In particular, FN-coated OH and NH2 surfaces 
supported high levels of these markers of osteoblastic differentiation.  Functional 
antibody blocking of the central cell-binding domain of pre-adsorbed FN completely 
inhibited mineralization, underscoring the importance of binding to FN to expression of 
the osteoblastic phenotype.  These results contribute to the development of design 







  Substrate-mediated control of cell function has been shown to be an effective 
means to direct cell response in many model systems.1-5  Surface chemistry is a tunable 
parameter that has been demonstrated to be a useful modulator of cell response through 
specific interactions of cell-surface receptors with adsorbed adhesive proteins.6-10  
Specifically, osteoblast function has been shown to be sensitive to surface properties 
using polymers,11,12metals13,14 and metal oxides,15,16 ceramics,17 and bioactive glasses.18-21  
Similarly, in vivo studies have shown osseointegration of implant surfaces to be surface 
chemistry-dependent.22,23  Although these studies have provided insight into relationships 
between surface properties and osteoblast cell function and osseointegration, other 
variables such as surface roughness, have not been well controlled.  For example, 
polymeric surfaces can undergo conformational rearrangements in response to 
environmental conditions and can exhibit differences in surface roughness and topology 
depending on processing or surface modifications.24,25  These factors can obscure 
correlations and complicate interpretation of these data.  To address these limitations, 
self-assembled monolayers (SAMs) of alkanethiols on gold have been used as a useful 
model system to systematically investigate the effects of well-defined surface chemistry 
without altering other surface properties such as roughness.  Long-chain, functionally-
terminated alkanethiols (HS-(CH2)n-X, n ≥ 10) adsorb from solution onto gold surfaces 
through gold-sulfur coordination at the chain head and the alkyl chains pack together to 
form stable, well-packed and ordered monolayers.26-28  Once assembled, the end group, 
X, comprises a uniform interface of designated surface chemistry.  SAMs of alkanethiols 




protein-cell interface.  Recent studies using SAMs of alkanethiols on gold have 
demonstrated surface chemistry-dependent modulation of osteoblast cell functions of 
adhesion, growth and migration.6,7,29,30   
The present study is an extension of previous work by our group to isolate the 
effects of surface chemistry on osteoblast cell function, as mediated through the adhesive 
protein fibronectin (FN).  Using SAMs of alkanethiols on gold with different surface 
chemistries (CH3, OH, COOH, NH2) and a fixed density of a single adhesive ligand FN, 
we have previously shown surface-dependent differences in the adsorbed conformation of 
FN, resulting in modulation of integrin receptor binding.6,7  These results are significant 
because cell adhesion to extracellular matrix proteins is primarily mediated by the 
integrin family of cell-surface receptors.31  Integrins not only anchor cells, supporting cell 
spreading and migration, but also trigger signals that regulate survival, proliferation and 
differentiation.31,32  Binding of integrins to the extracellular matrix protein fibronectin 
(FN) is critical for osteoblastic differentiation.33  Furthermore, we have shown that these 
surface chemistry-dependent differences in FN conformation and integrin binding give 
rise to differences in focal adhesion assembly, FAK activation and adhesion strength of 
an immature osteoblastic cell line.6  These findings provide a putative mechanism for 
surface-dependent differences in early cell response.34  In the present work, using this 
same model system, we investigated long-term effects of surface chemistry on 
osteoblastic cell function.  We show that, for the model cell line used, proliferation was 
relatively insensitive to surface chemistry, while large differences in markers of 
osteoblastic differentiation were exhibited.  Taken together, these results provide a 




advancing the development of engineering principles for the rational design of 
biomaterial surfaces. 
 
MATERIALS AND METHODS 
Cells and Reagents 
Human plasma FN and other tissue culture reagents were obtained from 
Invitrogen (Carlsbad, CA).  Fetal bovine serum was purchased from Hyclone (Logan, 
UT), bovine serum albumin and all other chemical reagents were obtained from Sigma 
Chemical (St. Louis, MO), while alamarBlueTM was purchased from BioSource 
International (Camarillo, CA).  HFN7.1 monoclonal antibody directed against human 
plasma FN was obtained from the Developmental Studies Hybridoma Bank (Iowa City, 
IA).  MC3T3-E1 cells, an immature osteoblast-like cell line, were obtained from the 
RIKEN Cell Bank (Tokyo, Japan).  Prior to seeding on FN-coated substrates, MC3T3-E1 
cells were maintained in α-Modified Eagle’s Medium supplemented with 10% fetal 
bovine serum and 1% penicillin-streptomycin and passaged every 2 days using standard 
techniques. 
 
Model Surfaces with Well-Defined Chemistries 
 Self-assembled monolayers (SAMs) of alkanethiols on gold were used as model 
substrates with well-defined chemistries.  Alkanethiols 1-dodecanethiol (HS-(CH2)11-
CH3), 11-mercapto-1-undecanol (HS-(CH2)11-OH) and 11-mercaptoundecanoic acid (HS-
(CH2)10- COOH) were purchased from Aldrich Chemical (Milwaukee, WI) and used as 




(CH2)12-NH2), was synthesized and purified as described previously.6  SAMs of their 
respective alkanethiols are referred to hereafter as CH3, OH, COOH and NH2 SAMs.  
Gold-coated glass coverslips were prepared by sequential deposition of optically 
transparent films of titanium (100 Å) and gold (200 Å) onto clean glass via an electron 
beam evaporator (Thermionics Laboratories, Hayward, CA) operating at 2 x 10-6 torr 
with a deposition rate of 2 Å/s.  Freshly prepared gold surfaces were immersed in 
ethanolic alkanethiol solutions (1.0 mM in absolute ethanol), and SAMs were allowed to 
assemble for 12 hr.  Surfaces were characterized by contact angle and X-ray 
photoelectron spectroscopy.6  Prior to FN coating, SAMs were rinsed in ethanol, dried 
with N2, and allowed to equilibrate in Dulbecco’s phosphate buffered saline (DPBS: 137 
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4⋅7H2O, 1.5 mM KH2PO4, 0.9 mM 
CaCl2⋅2H2O, 1 mM MgCl2⋅6H2O, pH 7.4) for 15 min.  SAMs were coated for 30 min at 
room temperature with FN diluted in DPBS to produce equivalent FN surface densities 
among SAMs (40 ng/cm2) and subsequently blocked for 30 min in 1% heat-denatured 
bovine serum albumin as described previously. 6,7 
 
Proliferation 
Confluent MC3T3-E1 cells were synchronized by culturing under serum-free 
conditions (α-MEM + 0.1% albumin) for 3 days.  Cells were then seeded at a low density 
(20 cells/mm2) to insure logarithmic growth, in αMEM supplemented with 10% FBS 
onto FN-coated (40 ng/cm2) SAMs.  After 30 minutes, a 1:10 dilution of alamarBlueTM 
was added to cells, as well as to cell-free controls.  Reduction of the alamarBlueTM dye, 




plating, was utilized as a convenient method to quantify proliferation.  Since this method 
is an indirect measure of cell number (reduction alamarBlueTM of is proportional to 
metabolic activity), measurement of cell number through DNA incorporation of SYBR 
Green I (Molecular Probes; Eugene, OR) intercalating dye was quantified as an 
independent measure of cell number.  Cells were lysed in PBS with 0.1 % SDS, lysates 
were incubated in SYBR Green I (diluted 1:10,000 in 10 mM Tris-EDTA, pH 8.0, per 
manufacturer’s instructions) and incorporation was measured by fluorescence (485 nm 
excitation, 535 nm emission) and converted to cell number using a standard curve.  
 
Osteoblast-Specific Gene Expression  
MC3T3-E1 cells were seeded (100 cells/mm2) on FN-coated (40 ng/cm2) SAMs 
in αMEM with 10% FBS, 1% penicillin-streptomycin (day 0).  Subsequent media 
changes, starting on day 1, were supplemented with 50 µg/mL ascorbic acid and 3 mM 
Na-β-glycerophosphate.  Day 7 cultures were lysed and homogenized by QIAshredder 
column.  Total RNA was isolated using the RNEasy RNA isolation kit.  cDNA synthesis 
was performed on DNaseI-treated (25 Kunitz units, for 15 min) total RNA (1 µg) by 
oligo(dT) priming using the Superscript II Preamplification System.  Real-time PCR 
using SYBR Green was performed with the ABI Prism 7700 Sequence Detection System 
(Applied Biosystems; 40 cycles; melting, 15 s at 95 ºC; annealing and extension, 60 s at 
60 ºC). 35,36  Reaction solutions included SYBR Green PCR Mastermix, 100 µM forward 
and reverse primers (Table 6.1), and 1 µL cDNA template in a 30 µL volume.  Gene 
transcript concentration in template cDNA solution was quantified by generation of a 




plotting the log of concentration versus the CT value (the cycle number at which a 
threshold fluorescence value is reached).  Standards for each gene were amplified from 
template cDNA using real-time oligonucleotides and purified using a Qiagen agarose gel 
extraction kit.35,36 
 
Alkaline Phosphatase Activity 
Alkaline phosphatase (ALP) activity was quantified using a modification of the 
method of Sodek and Berkman.35,36  MC3T3-E1 cells were seeded (100 cells/mm2) on 
FN-coated (40 ng/cm2) SAMs in αMEM with 10% FBS, 1% penicillin-streptomycin.  
Subsequent media changes, starting on day 1, were supplemented with 50 µg/mL 
ascorbic acid and 3 mM Na-β-glycerophosphate.  On day 7, cells were rinsed and scraped 
into ice-cold 50 mM Tris-HCl.  Cells were lysed by sonication and normalized for total 
protein as determined by MicroBCA (Pierce, Rockford, IL).  ALP activity was quantified 
by reaction with 60 µg/mL 5-methyl umbelliferyl phosphate fluorescent substrate in 
diethanolamine buffer (pH 9.5).  Sample fluorescence was measured on a HTS 7000 Plus 
BioAssay Reader (Perkin Elmer, Norwalk, CT) at 360 nm excitation, 465 nm emission.  
ALP activity was calculated using a purified calf intestinal ALP standard. 
 
Matrix Mineralization 
MC3T3-E1 cells were seeded (100 cells/mm2) and cultured on FN-coated (40 
ng/cm2) SAMs in αMEM supplemented with 10% FBS, 1% penicillin-streptomycin, 50 
µg/mL ascorbic acid, and 3 mM Na-β-glycerophosphate.  Following 14 days of culture, 




was added to each dish and plates were incubated under uniform light exposure for 30 
min.  The stain was then fixed in Na2SO3 for 2 min, rinsed and dried.  Plates were scored 
for percent mineralization using Image Pro Plus image acquisition and analysis software 
(Media Cybernetics, Silver Springs, MD).  Mineral-phase characteristics of ethanol-fixed 
cultures were determined by Fourier transform infrared (FT-IR) spectroscopy (Nicolet 
Magna 550; ThermoNicolet, Madison, WI).36  For FN-blocking antibody experiments, 10 
µg/mL HFN7.1 was added to culture media after 24 hours seeding (day 1), and added 
with media changes for the remainder of the 14 day culture. 
 
Statistical Analyses 
Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS Inc., IL).  For gene 
expression, analyses were performed following logarithmic transformation of the data in 
order to make the variance independent of the mean.36  For treatments that were 
determined to be significant, pair-wise comparisons were performed using Tukey post-
hoc test.  A 95% confidence level was considered significant. 
 
RESULTS 
Previous work using the same model system indicated that for early adhesion 
times (under 4 hours), surface chemistry modulates integrin binding and focal adhesion 
assembly, composition, and signaling.6,7  To examine the effects of surface chemistry on 
long-term cell functions, we evaluated proliferation, osteoblastic gene expression, ALP 
activity and matrix mineralization for MC3T3-E1 cells cultured on FN-coated SAMs.  A 




among surfaces.  This value represents the saturation density for the OH SAM and is the 
lowest saturation density of all SAMs examined.6  Under appropriate culture conditions, 
the MC3T3-E1 cell line expresses osteoblast-specific genes and produces mineralized 
nodules, undergoing the developmental stages associated with differentiating 
osteoblasts.38,39  Furthermore, using this cell line, we have previously demonstrated that 
osteoblastic differentiation and matrix mineralization require binding to FN.35 
 
Cell Proliferation 
We investigated the effects of surface chemistry on proliferation of MC3T3-E1 
cells seeded on FN-coated (40 ng/cm2) SAMs.  Quantification of metabolic activity via 
alamarBlueTM revealed no differences in proliferation among surfaces, with the exception 
of a ~30 % increase in cell number on the COOH surface with respect to the OH surface 
at both day 2 and day 3 (Figure 6.1).  Since this assay relies on measuring metabolic 
activity, which may vary as a function of culture confluence, total DNA was quantified 
by SYBR Green incorporation.  DNA quantification measurements revealed no 
significant differences among SAMs, in general agreement with the alamarBlueTM data, 
as well as with visual inspection of cultures (data not shown). 
 
Osteoblastic Gene Expression is Surface Chemistry-Dependent 
Osteoblastic differentiation on FN-coated SAMs was evaluated via real-time RT-
PCR.  Markers of osteoblastic differentiation, alkaline phosphatase (ALP), osteocalcin 
(OCN), bone-sialoprotein (BSP), as well as the house-keeping gene β-actin (BA), were 




differences following the pattern OH = NH2 > COOH = CH3, with expression levels for 
OH and NH2 surfaces approximately twice the levels for the COOH and CH3 (Figure 
6.2).  β-actin gene expression showed no differences among surfaces, demonstrating no 
differences in cell number among cultures.  This is consistent with the small differences 
observed in proliferation. 
 
Alkaline Phosphatase Activity 
Although considerable differences in ALP gene expression at day 7 were 
observed, ALP enzymatic activity remained relatively constant among SAMs.  However, 
~40% higher activity on the OH surface with respect to the NH2 surface was observed 
(Figure 6.3).  This is possibly indicative of regulation at the translational or post-
translational levels. 
 
Surface Chemistry-Dependent Differences in Matrix Mineralization 
 Staining by von Kossa, in which phosphate deposits stain black, revealed that 
matrix mineralization varied significantly among SAMs.  The OH and NH2 
functionalities supported high levels of mineralization, comparable to levels observed on 
FN-coated tissue culture polystyrene (data not shown), while mineralization on the 
COOH and CH3 surfaces was negligible (Fig. 6.4).  In order to determine if the matrix 
mineralization observed was biologically equivalent carbonate-containing hydroxyapatite 
or non-biological precipitation, FT-IR spectroscopy was performed (Fig. 6.5).  A 
phosphate peak at ~1100 cm-1, indicative of matrix mineral content, and an amide I peak 




presence of a phosphate doublet peak (seen at ~560 cm-1 and as a shoulder at ~605 cm-1), 
indicating the presence of crystallized phosphate, for matrices on the OH and NH2 
surfaces, indicates that mineralization on these surfaces is crystalline hydroxyapatite.  
FT-IR analysis of mineralized samples revealed the presence of a carbonate peak at ~870 
cm-1 for matrices on the OH and NH2 surfaces, indicating biologically equivalent 
carbonate-containing hydroxyapatite on these surfaces.  
To examine the role of the pre-adsorbed human FN on SAMs, cells were cultured 
in the presence of HFN7.1, a monoclonal antibody that blocks integrin binding to the 
central cell binding domain of human FN, without cross-reacting with either bovine or 
murine FN.40  Importantly, blocking with HFN7.1 antibody completely inhibited 
mineralization, indicating that adhesion to FN is critical to expression of the osteoblastic 
phenotype on these substrates and demonstrating the importance of the FN adsorbed prior 
to cell seeding (Fig. 6.6). 
 
DISCUSSION 
 A fundamental understanding of cell-protein-surface interactions is critical to the 
rational design of biomaterials to elicit directed cell and tissue response.  Previously, 
using SAMs of alkanethiols on gold, we demonstrated that surface chemistry modulates 
the adsorbed conformation of the adhesive protein, FN, giving rise to large differences in 
adhesion strength and the early cell responses of integrin binding, focal adhesion 
assembly and signaling.6  In the present work, we extend this mechanistic examination of 
substrate-directed control of cell function, focusing on the later cell responses of 




demonstrated significant surface chemistry-dependence.  The OH and NH2 surfaces 
supported elevated levels of expression of osteoblast-specific genes for ALP (cleaves 
phosphate groups making them available for incorporation into the inorganic phase), BSP 
(an enhancer of hydroxyapatite nucleation) and OCN (binds hydroxyapatite).  The OH 
and NH2 surfaces also supported high levels of matrix mineralization that was shown to 
be biologically equivalent carbonate-containing hydroxyapatite. 
The elevated levels of osteoblastic gene expression and matrix mineralization on 
the OH and NH2 surfaces correlated well with enhanced α5β1 integrin binding and FAK 
activation on these chemistries,6 consistent with critical roles for α5β1 binding to FN and 
FAK in osteoblastic differentiation.41,41a  Notably, blocking antibodies against the major 
integrin binding site in FN completely inhibited mineralization on these substrates.  This 
result demonstrates that interactions between integrins and adsorbed human FN are 
essential to differentiation on these surfaces.  Interestingly, the COOH substrate 
supported insignificant amounts of mineralization, even though this functionality 
provided for equivalent levels of α5β1 binding and FAK activation as the chemistries that 
supported mineralization.  An explanation for this result is that the pro-differentiation 
signals triggered by α5β1 binding are inhibited by another adhesive interaction.  The 
COOH surface, in contrast to the NH2 and OH substrates, exhibited significant αVβ3 
integrin binding.6  Avioli and colleagues demonstrated that αVβ3 integrin binding 
inhibited osteoblastic differentiation and mineralization without altering FAK activation 
in this cell line.42  These results suggest that the interplay between of multiple integrins 




specific integrins to direct cell response may evolve to targeting multiple integrins in 
concert. 
Numerous studies have shown substrate-dependent differences in osteoblast cell 
response,14,20,21 however, surface properties were not controlled.  To address this, model 
surfaces have been used to examine the individual effects of surface chemistry43 and 
roughness.44,45  Several groups have used SAMs of alkanethiols on gold to examine the 
effects of surface chemistry on cell function.  For example, McClary et al. demonstrated 
surface chemistry-dependent differences in fibroblast adhesion, spreading and RhoA 
signaling on FN-coated SAMs of COOH and CH3 surface chemistries.46,47  Scotchford et 
al. reported modulation of osteoblast adhesion on FN-coated SAMs of COOH, OH and 
CH3 surface chemistries, showing qualitative differences in integrin binding and 
localization of vinculin to focal adhesions as well as seeding efficiency.29   
Other work has focused on the use of alkanethiols on gold to examine the effects 
of surface chemistry on non-biological mineralization.  In contrast to the biological 
hydroxyapatite reported in the present work, non-biological apatite crystallization was 
reported on SAMs incubated in protein-free saline solutions with the following trend: 
COOH >> OH = NH2 >> CH3.48  It is interesting to note the opposite trends in these two 
forms of mineralization, indicating the very different mechanisms of mineralization in the 
two systems. 
We propose a model in which surface chemistry-dependent differences in FN 
adsorption induce differences in integrin binding, differentially regulate focal adhesion 
assembly and signaling which, in turn, modulates the cellular functions of cell adhesion 




contribute to the development of design principles for the engineering of surfaces that 
direct cell adhesion for biomedical and biotechnology applications. 
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ALP 5′-GGGACTGGTACTCGGATAACGA 5′-CTGATATGCGATGTCCTTGCA 71 6671532 
OCN 5′-CGGCCCTGAGTCTGACAAA 5′-GCCGGAGTCTGTTCACTACCTT 68 X04142 
BSP 5′-TCCTCCTCTGAAACGGTTTCC 5′-GGAACTATCGCCGTCTCCATT 73 L20232 


































CH3 OH COOH NH2
Figure 6.1. Osteoblast proliferation shows little dependence on surface chemistry. 
MC3T3-E1 cells were cultured on SAMs coated with equivalent FN surface densities (40 
ng/cm2).  Cell numbers were quantified indirectly through metabolic activity via 
alamarBlueTM reduction (* - vs. OH (2 days); † - vs. OH (3 days)).  Data is plotted as 





















































































































p < 2 x 10-11p < 3 x 10-9 ***
* *
p < 3 x 10-9
Figure 6.2. Surface chemistry modulates osteoblastic gene expression. MC3T3-E1 cells 
were cultured on SAMs coated with equivalent FN surface densities (40 ng/cm2). 
Osteoblast-specific gene expression was quantified by real-time RT-PCR (* vs. CH3 and



































Figure 6.3. Osteoblast alkaline phosphatase activity shows little dependence on surface 
chemistry. MC3T3-E1 cells were cultured on SAMs coated with equivalent FN surface 
densities (40 ng/cm2) for 7 days.  Pair-wise comparison showed significant differences 
between two groups (* vs. NH2).  Data is plotted as mean ± standard error. 
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Figure 6.4. Surface chemistry modulates matrix mineralization. MC3T3-E1 cells were
cultured on SAMs coated with equivalent FN surface densities (40 ng/cm2).  Mineralized
deposits (black) at day 14 varied among surface chemistries.  Pair-wise comparison
showed significant differences between surface chemistries (* vs. CH3 and COOH; p <



































Figure 6.5. Surface chemistry modulates composition and structure of matrix
mineralization, as shown by FT-IR.  MC3T3-E1 cells were cultured on 14 days on SAMs
coated with equivalent FN surface densities (40 ng/cm2).  Spectra show peaks
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Figure 6.6. Osteoblast differentiation requires integrin binding to FN. MC3T3-E1 cells 
were cultured on SAMs coated with equivalent FN surface densities (40 ng/cm2). 
Blocking with HFN7.1 antibody, specific to human FN, demonstrated that integrin 
binding to pre-adsorbed FN is essential for differentiation.   
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                       CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK 
 
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK 
The goal of this thesis research was to engineer well-defined surfaces to direct 
integrin binding and signaling to promote osteoblast differentiation.  The approach of 
controlling cell receptor-ligand interactions through underlying substrata represents a 
versatile method to manipulate cellular responses for biomaterial and tissue engineering 
applications.  By focusing on osteoblasts, the cells responsible for bone matrix production 
and mineralization, this research is relevant to the engineering of surfaces that may lead 
to improvements in biomaterials for orthopedic implants, grafting substrates and tissue 
engineering scaffolds.  By implementing a bioengineering analysis of integrin-mediated 
adhesion to adsorbed FN as a function of the underlying chemistry, we have made 
important contributions toward establishing a fundamental framework for the engineering 
of surfaces to direct cell function.  A significant advantage of our experimental system 
over previous studies is the use of model surfaces consisting of SAMs of alkanethiols on 
gold presenting well-defined chemistries.  Using this model system, we conclude that 
surface chemistry-dependent differences in FN adsorption induce differences in integrin 
binding, differentially regulate focal adhesion assembly and signaling which, in turn, 
modulate cell adhesion strength, osteoblast-specific gene expression and matrix 
mineralization.  Specifically, OH and NH2 chemistries provided enhanced functional 
presentation of adsorbed FN, targeting integrin α5β1 and promoting osteoblastic 
differentiation.  The CH3 chemistry most likely performed poorly due to FN inactivation 




adsorbed on the COOH surface, able to support high levels of many adhesive functions 
(integrin binding, focal adhesion assembly and signaling), most likely failed to promote 
osteoblastic differentiation due to a lack of integrin binding specificity.  In addition, new 
methods to quantify integrin binding and focal adhesion assembly were introduced and 
validated.  Overall, this thesis makes important contributions to the development of 
design principles for the engineering of surfaces that direct cell adhesion for biomedical 
and biotechnology applications.   
Recommendations for future experiments include many exciting possibilities.  
Functional antibody blocking experiments could be carried out in order to further 
elucidate the role specific integrins in surface-mediated cell response.  Similarly, 
important information could be gained by further determination of the signaling pathways 
giving rise to surface chemistry-dependent differences in cell function.  The use of 
siRNA to block expression molecules involved in cell adhesion, including the ones 
mentioned above, as well as focal adhesion proteins and adhesive proteins could be 
employed to gain additional insight into surface-dependent cell function.   
The identification of surface chemistries that promote osteoblastic differentiation 
raises the question of whether osteoblastic cell response to surface chemistry has a 
“minimum surface chemistry density” to invoke a similar response, and whether surface 
chemistry effects may be additive or synergistic.  This could be addressed through mixed 
surface chemistry experiments using SAMs.  Also, interesting work may be carried out 
with surface chemistry gradients of mixed chemistries, with one possible goal of 
potentially overcoming difficulties in non-homogeneous cell population of synthetic 




address whether or not surface chemistry similarly modulates cell response at the tissue 
level and with the enormous amount of added complexity from being placed in the in 
vivo environment. 
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